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Abstract
Nucleocytoplasmic transport (NCT) defects have been implicated in neurodegenerative dis-
eases such as C9ORF72-associated amyotrophic lateral sclerosis and frontotemporal
dementia (C9-ALS/FTD). Here, we identify a neuroprotective pathway of like-Sm protein 12
(LSM12) and exchange protein directly activated by cyclic AMP 1 (EPAC1) that sustains the
nucleocytoplasmic RAN gradient and thereby suppresses NCT dysfunction by the
C9ORF72-derived poly(glycine-arginine) protein. LSM12 depletion in human neuroblas-
toma cells aggravated poly(GR)-induced impairment of NCT and nuclear integrity while pro-
moting the nuclear accumulation of poly(GR) granules. In fact, LSM12 posttranscriptionally
up-regulated EPAC1 expression, whereas EPAC1 overexpression rescued the RAN gradi-
ent and NCT defects in LSM12-deleted cells. C9-ALS patient-derived neurons differentiated
from induced pluripotent stem cells (C9-ALS iPSNs) displayed low expression of LSM12
and EPAC1. Lentiviral overexpression of LSM12 or EPAC1 indeed restored the RAN gradi-
ent, mitigated the pathogenic mislocalization of TDP-43, and suppressed caspase-3 activa-
tion for apoptosis in C9-ALS iPSNs. EPAC1 depletion biochemically dissociated RAN-
importin β1 from the cytoplasmic nuclear pore complex, thereby dissipating the nucleocyto-
plasmic RAN gradient essential for NCT. These findings define the LSM12-EPAC1 pathway
as an important suppressor of the NCT-related pathologies in C9-ALS/FTD.
Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that manifests as pro-
gressive loss of motor neurons, paralysis, and respiratory failure [1]. ALS shares pathological
hallmarks with frontotemporal dementia (FTD), a clinically distinct neurodegenerative disor-
der accompanied by behavioral changes and language difficulties [2,3]. Familial ALS/FTD is
most commonly caused by the pathogenic expansion of GGGGCC hexanucleotide repeats in
the C9ORF72 locus [4–6]. Additional genetic factors associated with ALS/FTD include TDP-
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43 and FUS, the two RNA-binding proteins that form cytoplasmic aggregates in the affected
neurons of ALS/FTD subtypes [7]. Nonetheless, the prevalence of sporadic ALS/FTD and their
genetic heterogeneity suggest the multifactorial nature of these genetic disorders [8–10] and
the substantial contribution of nongenetic factors to ALS/FTD pathogenesis [11,12].
In C9ORF72-associated ALS/FTD, the RNA polymerase II-associated factor 1 (PAF1) com-
plex and transcription elongation factor SUPT4H1 (suppressor of Ty 4 homolog 1) promote
bidirectional transcription from C9ORF72-associated repeats [13,14]. These RNA molecules
containing repetitive sequences form pathogenic secondary structures that sequester RNA-
binding proteins in a conformation-specific manner and interfere with their relevant function
[15,16]. Accordingly, it has been suggested that the gain of RNA toxicity is responsible for the
pathogenesis of C9ORF72-associated ALS/FTD [17,18]. Furthermore, C9ORF72 repeats
encoded in both sense and antisense RNAs are translated into 5 different dipeptide repeat
(DPR) proteins via repeat-associated non-AUG translation of all possible reading frames
[19,20]. While all DPR proteins are detected in C9ORF72-related ALS/FTD patients [19,21], it
has been demonstrated that a subset of DPR proteins (i.e., poly(GR), poly(PR), and poly(GA)
proteins) form intracellular inclusions and impair specific aspects of cellular physiology
[2,22,23]. Thus, the cytotoxic effects of these noncanonical translation products are emerging
as the key mechanism that contributes to neurodegeneration [24].
The arginine-containing DPR proteins, poly(GR) and poly(PR), associate with RNA-bind-
ing proteins that display low complexity sequence domains (LCDs) and form membrane-less
intracellular organelles via phase separation [25–29]. Poly(GR) and poly(PR) proteins localize
to nucleoli, translocate the nucleolar phosphoprotein B23 (also known as NPM1) into the
nucleoplasm, and impair both pre-mRNA splicing and ribosomal RNA processing
[25,26,30,31]. DPR-induced nucleolar stress is thus emerging as one of the key pathogenic
mechanisms underlying C9ORF72-associated ALS/FTD [32]. On the other hand, both DPR
proteins promote the formation of stress granules (SGs) [25,28,33,34], cytoplasmic assemblies
of ribonucleoproteins that are formed under diverse cellular stresses and are thought to sup-
port cellular homeostasis of RNA and RNA-binding proteins [35,36]. Genetic studies in yeast,
Drosophila, and in vitro cell culture models of C9ORF72-associated ALS/FTD have further
identified several cellular factors involved in nucleocytoplasmic transport (NCT) as genetic
modifiers of DPR cytotoxicity [22,37–41]. A compelling model suggests that the nonfunctional
sequestration of key NCT factors into DPR-induced SGs disrupts NCT, thereby contributing
to neurodegeneration in C9ORF72-associated ALS/FTD [33]. More direct effects of poly(GR)
and poly(PR) proteins on karyopherin function via biochemical association have also been
shown in in vitro assays [41].
Polyglutamine (polyQ) expansions of ataxin-2 (ATXN2) are associated with a high risk of
ALS [42]. Transgenic ATXN2 depletion or loss-of-function mutation in ATXN2 mitigates
neurodegenerative phenotypes in genetic disease models of ALS/FTD [33,39,43,44]. Because
ATXN2 protein localizes to SGs and is necessary for SG assembly under oxidative stress condi-
tions [45,46], it has been proposed that polyQ expansions cause gain-of-function effects on
ATXN2-dependent assembly of SGs, which promotes neurodegeneration. In contrast, loss of
ATXN2 function may suppress neurodegeneration, likely through impairment of SG forma-
tion [43,47,48]. Other ALS/FTD-related genetic factors (e.g., TDP-43, FUS, and HNRNPA1)
harbor LCDs that similarly regulate SG assembly via liquid–liquid phase separation [49–52]. It
has also been shown that C9ORF72 associates with SGs and contributes to SG formation and
its clearance via autophagy [53,54]. Loss of C9ORF72 function thus hypersensitizes the affected
cells to cellular stress and is likely involved in the ALS/FTD pathogenesis given that repeat
expansion in the C9ORF72 locus reduces endogenous C9ORF72 expression [53,54].
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We previously identified like-Sm protein 12 (LSM12) as an ATXN2-associating adaptor
protein that forms a translational activator complex important for circadian rhythms in Dro-
sophila [55]. LSM12 recruits the Drosophila-specific translation factor, TWENTY-FOUR [56],
to the ATXN2 protein complex, induces translation of the circadian clock gene, period, and
maintains 24-hour periodicity in circadian locomotor behaviors [55,57,58]. Since the bio-
chemical association of LSM12 with ATXN2 is well conserved between Drosophila and
humans [55], we asked whether LSM12 would cooperate with ATXN2 to facilitate neurode-
generation. Here, we demonstrate an unexpected role of LSM12 and its downstream effector,
exchange protein directly activated by cyclic AMP 1 (EPAC1; also known as RAPGEF3) in
establishing a robust nucleocytoplasmic gradient of RAN-GTP. Consequently, LSM12-EPAC1
constitutes an ATXN2-independent neuroprotective pathway that sustains NCT and sup-
presses the cellular pathogenesis of poly(GR)-induced neurodegeneration.
Results
LSM12 depletion attenuates SG formation upon arsenite-induced oxidative
stress
Given that SG assembly is suppressed by loss of ATXN2 function [43,45,46], we asked if ATX-
N2-associated LSM12 plays a similar role in SG formation. To better analyze the kinetics of SG
assembly, we induced mild oxidative stress in the SH-SY5Y human neuroblastoma cell line
with 50-μM arsenite and then visualized the formation of G3BP1- or PABPC1-positive SGs.
Under these conditions, SG assembly underwent a gradual maturation process whereby the
average size of SGs per cell became larger through fusion over 2 hours after incubation with
arsenite (Fig 1A and 1B). LSM12 depletion by stable transfection of short hairpin RNA
(shRNA), however, decreased the relative proportion of SG-positive cells, suggesting that loss
of LSM12 function may increase the threshold for initiating SG assembly. Further quantifica-
tion revealed that each LSM12-depleted cell initially formed fewer SGs than control cells and
displayed a smaller average size of SGs during maturation. The SG phenotypes in LSM12-de-
pleted cells were insensitive to puromycin treatment that destabilizes polysomes and promotes
SG formation in control cells (S1A Fig) [59]. To further probe LSM12 effects on SG disassem-
bly, we induced SG formation with a high dose of arsenite (500 μM) for 1 hour and then traced
SG disassembly after the removal of arsenite from cell culture media (S1B and S1C Fig). Under
the acute oxidative stress, weaker effects of LSM12 depletion on SG formation persisted during
SG disassembly and became undetectable 4 hours after recovery. LSM12 effects on SGs were
relatively specific to arsenite-induced oxidative stress since SG formation under sorbitol-
induced osmotic stress [60] was comparable between control and LSM12-depleted cells (S2A
Fig). These SG phenotypes in LSM12-depleted cells also correlated with lower levels of eukary-
otic translation initiation factor 2 subunit α (EIF2α) phosphorylation upon oxidative stress,
but not upon other cellular stresses [61,62] (S2B and S2C Fig).
In fact, LSM12 depletion modestly decreased endogenous levels of ATXN2 protein (Fig
1C). Whereas LSM12 may stabilize ATXN2 through the formation of a protein complex, we
found that ATXN2 overexpression partially rescued the average number and size of arsenite-
induced SGs in LSM12-depleted cells (Fig 1D and 1E). However, a lower percentage of SG-
positive cells in LSM12-depleted cells was not evidently rescued by ATXN2 overexpression,
indicating more direct effects of LSM12 on the threshold for initiating SG assembly. ATXN2
depletion, on the other hand, did not affect endogenous levels of LSM12 protein (Fig 1C) but
caused an impairment in SG formation similar to that observed in LSM12-depleted cells (Fig
1A and 1B). Moreover, we observed the nonadditive effects of LSM12 and ATXN2 on arsenite-
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induced SG assembly, suggesting that these factors may act together in the same genetic path-
way to regulate SG formation under oxidative stress conditions.
LSM12 depletion disrupts the RAN gradient and impairs NCT upon
oxidative stress
Emerging evidence indicates that SGs sequester cellular factors important for NCT and
thereby interfere with NCT under diverse cellular or genetic stresses [33,63]. Consistent with
this, it has been shown that inhibition of SG assembly by ATXN2 depletion or treatment with
integrated stress response inhibitor (ISRIB) rescues stress-induced disruption of NCT, identi-
fying SG inhibition as a neuroprotective mechanism [33]. Given LSM12 effects on arsenite-
Fig 1. LSM12 depletion attenuates SG formation upon arsenite-induced oxidative stress. (A) LSM12 and ATXN2 promote arsenite-induced SG assembly, likely via the
same genetic pathway. SH-SY5Y cells stably expressing each shRNA were incubated with 50-μM sodium arsenite (NaAsO2) for the indicated time and then co-stained
with anti-G3BP1 antibody (red), anti-PABPC1 antibody (green), and Hoechst 33258 (blue) to visualize SGs and the nucleus, respectively. (B) The percentage of SG-
positive cells, the number of SGs per SG-positive cell, and the size of SGs were quantified using ImageJ software and averaged (n = 15–19 confocal images of random fields
of interest obtained from 3 independent experiments; n = 329–1,045 cells). Error bars indicate SEM. ��P< 0.01, ���P< 0.001 to controlshRNA cells at a given time point, as
determined by 2-way ANOVA with Tukey post hoc test. (C) Immunoblotting of total cell extracts from individual shRNA cell lines with anti-ATXN2, anti-LSM12, and
anti-tubulin (loading control) antibodies. The abundance of each protein was quantified using ImageJ and normalized to that of tubulin. Relative protein levels were then
calculated by normalizing to those in controlshRNA cells. Data represent means ± SEM (n = 3). n.s., not significant; �P< 0.05, ��P< 0.01, ���P< 0.001, as determined by
2-way ANOVA with Tukey post hoc test. (D, E) Overexpression of LSM12, but not ATXN2, restores arsenite-induced SG assembly in LSM12-depleted cells. ControlshRNA
and LSM12shRNA cells were transfected with an expression vector for FLAG, FLAG-tagged LSM12, or FLAG-tagged ATXN2. Arsenite-induced SG assembly was
quantified 48 hours after transfection. Data represent means ± SEM (n = 15–16 confocal images obtained from 3 independent experiments; n = 200–820 cells). n.s., not
significant; �P< 0.05, ��P< 0.01, ���P< 0.001 to controlshRNA cells expressing FLAG at a given time point, as determined by 2-way ANOVA with Tukey post hoc test. All
underlying numerical values are available in S1 Data. ANOVA, analysis of variance; ATXN2, ataxin-2; LSM12, like-Sm protein 12; SEM, standard error of the mean; SG,
stress granule; shRNA, short hairpin.
https://doi.org/10.1371/journal.pbio.3001002.g001
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induced SG assembly, we hypothesized that LSM12 depletion would mitigate the arsenite-
induced impairment of NCT. To quantify NCT activity in SH-SY5Y cells, we employed a
green fluorescent protein (GFP) reporter harboring both nuclear localization and export sig-
nals (shuttle-GFP/S-GFP) that predominantly localizes to the cytoplasm under basal condi-
tions [64]. Any change in the ratio of nuclear to cytoplasmic S-GFP localization upon
pharmacological or genetic perturbation would reflect quantitative alterations in NCT func-
tion. Consistent with previous findings [33], arsenite-induced oxidative stress significantly
increased the nuclear fraction of S-GFP, whereas ATXN2 depletion or ISRIB treatment sub-
stantially blocked both SG formation and NCT defects upon oxidative stress (Fig 2A and 2B).
Surprisingly, LSM12 depletion facilitated rather than hindered the nuclear translocation of
S-GFP upon arsenite treatment (S3A Fig). Moreover, ATXN2 depletion or ISRIB treatment
failed to rescue the LSM12 phenotypes (Fig 2A and 2B). These effects were not specific to the
S-GFP reporter since similar NCT defects were observed in LSM12-depleted cells expressing
S-tdTomato (S-tdT), an independent NCT reporter that predominantly localizes to the nucleus
under basal conditions [37] (S3B Fig). These findings convincingly demonstrate that LSM12
sustains NCT in a manner independent of ATXN2 or SG assembly under oxidative stress
conditions.
RAN is an evolutionarily conserved, small GTPase that shuttles between the nucleus and
cytoplasm in 2 alternating forms: GTP-bound and GDP-bound [65–67]. The opposing activi-
ties of RAN GTPase-activating protein 1 (RANGAP1) at the cytoplasmic side of the nuclear
pore complex and of chromatin-associating RAN guanine nucleotide exchange factor (RAN-
GEF; also known as RCC1), establish a steep nucleocytoplasmic gradient of RAN-GTP [68,69].
The RAN-GTP/GDP state subsequently switches its binding affinity between nuclear transport
factors, thereby defining the directional NCT of a given cargo protein via the nuclear pore
complex [70]. Disruption of the nucleocytoplasmic RAN gradient has been observed in neuro-
degenerative diseases, such as C9ORF72-ALS, Huntington’s disease, and Alzheimer’s disease
[33,71,72]. We thus asked whether an abnormal RAN gradient would explain LSM12-deple-
tion phenotypes in NCT. In control cells, arsenite-induced oxidative stress increased the rela-
tive abundance of cytoplasmic RAN (Fig 2C and 2D). ATXN2 depletion or ISRIB treatment
suppressed the arsenite-induced disruption of the RAN gradient, consistent with previous
observations [33]. On the other hand, LSM12 depletion itself was sufficient to disrupt the RAN
gradient, whereas arsenite treatment had no additive effects on the RAN gradient in
LSM12-depleted cells (Fig 2C and 2D). Consistent with our observations in NCT assays,
ATXN2 depletion or ISRIB treatment negligibly affected RAN phenotypes caused by LSM12
depletion. It is puzzling that LSM12 depletion disrupts the RAN gradient regardless of arsenite
treatment while impairing NCT only under the oxidative stress. We speculate that there may
be a compensating mechanism for LSM12 deficiency in non-stressed cells to sustain NCT. In
this sense, LSM12 likely acts as a risk rather than a causative factor for NCT-relevant pathogen-
esis. Taken together, our data suggest that LSM12 has a role in establishing a basal RAN gradi-
ent, and these effects are likely distinct from LSM12 function in SG assembly.
LSM12 depletion facilitates the nuclear accumulation of C9ORF72-derived
poly(GR) protein and exacerbates its pathogenic effects
Given that pathogenic proteins implicated in ALS/FTD disrupt NCT via induction of SG for-
mation [33], we wondered if the loss of LSM12 function would exacerbate these cellular pro-
cesses, which are involved in neurodegeneration and possibly normal aging [73]. To test this
possibility, we employed C9ORF72-derived poly(GR) protein translated from a codon-opti-
mized synthetic cDNA encoding 100 GR repeats [74]. Since poly(GR) protein localizes to
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NPM1-positive nucleoli and causes nucleolar stress [25,26,30], we tested whether LSM12 con-
tributed to the nucleolar assembly of poly(GR) granules as well as poly(GR)-induced SG.
LSM12 depletion significantly increased the relative proportion of cells harboring poly(GR)-
induced SGs (Fig 3A and 3B). This contrasted with LSM12-depletion phenotype in that of cells
harboring arsenite-induced SGs, further indicating the stress-specific effects of LSM12 on SG
assembly. Nonetheless, the smaller G3BP-positive SGs in LSM12-depleted cells likely indicates
a role for LSM12 in the maturation process of poly(GR)-induced SGs, similar to that observed
in arsenite-induced SGs. LSM12 depletion caused more striking effects on the formation of
nuclear poly(GR) granules. Control cells gradually accumulated poly(GR) protein in nucleolar
Fig 2. LSM12 depletion disrupts the RAN gradient and impairs NCT upon oxidative stress. (A) LSM12 depletion impairs NCT under oxidative stress conditions in a
manner that is independent of ATXN2 or SG assembly. Individual shRNA cell lines were transfected with an expression vector for the S-GFP reporter. SG assembly was
then quantified 48 hours after transfection. Transfected cells were co-stained with anti-G3BP1 antibody (red) and Hoechst 33258 (blue). Where indicated, cells were
incubated with 50-μM NaAsO2 or PBS (vehicle control) for 2 hours to induce oxidative stress. Phospho-EIF2α–dependent SG assembly was blocked by treating with 2-
μM ISRIB for 3 hours before NaAsO2 incubation. DMSO was used as vehicle control for ISRIB. (B) NCT of S-GFP reporter proteins was quantified by calculating the
ratio of N/C fluorescence in individual cells. Two-way ANOVA detected significant interaction effects of arsenite and ISRIB treatments on NCT only in controlshRNA cells
(P = 0.0004). Data represent means ± SEM (n = 100–137 cells from 3 independent experiments). n.s., not significant; ���P< 0.001, as determined by Tukey post hoc test.
(C) LSM12 depletion disrupts the nucleocytoplasmic RAN gradient in a manner that is independent of ATXN2 or SG assembly. Cells were incubated with 2-μM ISRIB,
50-μM NaAsO2, or vehicle controls as described above and then co-stained with anti-RAN antibody (red), anti-G3BP1 antibody (green), and Hoechst 33258 (blue). (D)
The relative distribution of endogenous RAN proteins was quantified by calculating the ratio of N/C fluorescence. Two-way ANOVA detected significant interaction
effects of arsenite and ISRIB treatments on the RAN gradient only in controlshRNA cells (P< 0.0001). Data represent means ± SEM (n = 95–104 cells from 3 independent
experiments). n.s., not significant; ��P< 0.01, ���P< 0.001, as determined by Tukey post hoc test. All underlying numerical values are available in S1 Data. ANOVA,
analysis of variance; ATXN2, ataxin-2; GFP, green fluorescent protein; ISRIB, integrated stress response inhibitor; LSM12, like-Sm protein 12; N/C, nuclear to
cytoplasmic; NCT, nucleocytoplasmic transport; SEM, standard error of the mean; SG, stress granule; shRNA, short hairpin.
https://doi.org/10.1371/journal.pbio.3001002.g002
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granules after the transient transfection of cells with the poly(GR) expression vector (Fig 3A
and 3B). LSM12 depletion remarkably facilitated this process and increased the number of
nuclear poly(GR) granules per cell.
We next examined if these LSM12-depletion phenotypes led to any alterations in poly(GR)
toxicity. Overexpression of poly(GR) protein in control cells disrupted NCT in an ISRIB-sensi-
tive manner (Fig 3C and 3D), supporting that poly(GR) effects on NCT require SG formation
[33]. By contrast, ISRIB treatment failed to rescue poly(GR)-induced impairment of NCT in
Fig 3. LSM12 depletion facilitates the nuclear accumulation of C9ORF72-derived poly(GR) proteins and exacerbates their pathogenic effects. (A) LSM12 depletion
suppresses the maturation of poly(GR)-induced SGs but promotes the nuclear accumulation of poly(GR) granules. ControlshRNA and LSM12shRNA cells were transfected
with a GFP-GR100 expression vector and then co-stained with anti-G3BP1 antibody (red) and Hoechst 33258 (blue) at the indicated time after transfection. (B) The
assemblies of poly(GR)-induced SGs and nuclear poly(GR) granules were quantified as in Fig 1. Data represent means ± SEM (n = 23–25 confocal images obtained from 3
independent experiments; n = 424–513 GFP-GR100–positive cells). n.s., not significant; �P< 0.05, ���P< 0.001, as determined by Student t test. (C) ISRIB treatment
suppresses the poly(GR)-induced disruption of NCT in control cells, but not in LSM12-depleted cells. ControlshRNA and LSM12shRNA cells were co-transfected with
expression vectors for S-GFP and FLAG-GR100. Where indicated, cells were incubated with 2-μM ISRIB or DMSO (vehicle control) for 5 hours and then co-stained with
anti-FLAG antibody (red) and Hoechst 33258 (blue) 48 hours after transfection. (D) NCT of S-GFP reporter proteins was quantified as in Fig 2B. Data represent
means ± SEM (n = 142–166 cells from 3 independent experiments). n.s., not significant; ���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc test. (E)
LSM12 depletion exacerbates poly(GR)-induced disruption of the nuclear lamina. Control shRNA and LSM12shRNA cells were transfected with an expression vector for
GFP or GFP-GR100 and then co-stained with anti-lamin B1 antibody (red) and Hoechst 33258 (blue) to visualize nuclear envelope morphology 48 hours after transfection.
Yellow arrows indicate GFP-GR100–positive cells with severe disruption of the nuclear lamina. (F) Control cells expressing GFP-GR100 were scored for nuclear poly(GR)
granules and abnormal morphology of the nuclear lamina. The relative percentages of cells with severe nuclear laminar disruption were averaged from confocal images of
6 random fields of interest per condition (n = 55–69 GFP-GR100–positive cells from 3 independent experiments). Error bars indicate SEM. ���P<0.001, as determined by
Student t test. (G) The relative percentages of controlshRNA and LSM12shRNA cells with severe nuclear lamina disruption were quantified as described above. Data
represent means ± SEM (n = 10 confocal images obtained from 3 independent experiments; n = 183–297 GFP–or GFP-GR100–positive cells). n.s., not significant;
���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc test. All underlying numerical values are available in S1 Data. ANOVA, analysis of variance; GFP,
green fluorescent protein; LSM12, like-Sm protein 12; N/C, nuclear to cytoplasmic; NCT, nucleocytoplasmic transport; SEM, standard error of the mean; SG, stress
granule; shRNA, short hairpin.
https://doi.org/10.1371/journal.pbio.3001002.g003
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LSM12-depleted cells, an effect similar to that of LSM12 on NCT under oxidative stress condi-
tions. We further found that poly(GR) overexpression disrupted the integrity of the nuclear
envelope (Fig 3E). Abnormalities of the nuclear lamina induced by poly(GR) overexpression
were more severe in LSM12-depleted cells than control cells, indicating a strong correlation
between the presence of nuclear poly(GR) granules and abnormal morphology of the nuclear
envelop (Fig 3F and 3G). We observed comparable phenotypes in a cell line harboring a
CRISPR/Cas9-mediated deletion in the LSM12 genetic locus (S4 Fig). Taken together, these
results suggest that LSM12 delays the nucleolar deposition of poly(GR) protein, thereby sup-
pressing its cytotoxic effects.
An LSM12V135I mutant allele exhibits dominant-negative effects on the
RAN gradient
Large-scale genome-wide association studies have revealed an abundance of low-frequency
genetic variants associated with ALS patients [8–10]. This is also the case for ALS-associated
LSM12 loci, where several rare point mutations in the LSM12 coding sequence were detected
(http://databrowser.projectmine.com/). Given our observation that LSM12 suppresses the
nuclear assembly of ALS-relevant poly(GR) protein and its pathogenic effects, we hypothesized
that some of these LSM12 variants might display loss-of-function phenotypes, explaining their
presence in ALS patients. We, therefore, overexpressed either wild-type or point mutants of
LSM12 in control or LSM12-deleted cells and assessed their NCT-related functional activities.
We first confirmed that disruption of NCT upon arsenite-induced oxidative stress was
more severe in LSM12-deleted cells than control cells (Fig 4A and 4B), consistent with
LSM12-depletion phenotypes (Fig 2A and 2B). Overexpression of wild-type LSM12 rescued
LSM12-deletion phenotypes in NCT, whereas LSM12V135I, one of the LSM12 variants observed
in ALS patients, failed to do so. In fact, LSM12V135I overexpression was sufficient to impair
NCT in both control and LSM12-deleted cells regardless of arsenite treatment (Fig 4A and
4B). Since LSM12 deletion did not affect NCT in control cells not treated with arsenite,
LSM12V135I might have neomorphic effects on NCT possibly via genetic induction of oxidative
stress. Overexpression of LSM12V135I, but not wild-type LSM12, also promoted the assembly
of nuclear poly(GR) granules in control cells and increased the cell population that displayed
poly(GR)-induced SGs (Fig 4C and 4D).
Finally, we found that these NCT phenotypes were consistent with LSM12 effects on the
RAN gradient. Cytoplasmic mislocalization of RAN in LSM12-deleted cells was restored by
overexpression of wild-type LSM12 (Fig 4E and 4F). In contrast, LSM12V135I overexpression
potently disrupted the RAN gradient in control cells, but it did not exaggerate the RAN pheno-
type in LSM12-deleted cells. Considering that overexpression of neither wild-type LSM12 nor
LSM12V135I altered endogenous levels of LSM12 proteins in control cells (S5 Fig), these results
indicate the dominant-negative effects of LSM12V135I mutant on establishing a RAN gradient.
The LSM12V135I variant is detectable in other general databases for single nucleotide polymor-
phism in humans (e.g., https://www.ncbi.nlm.nih.gov/snp/rs1162569843). However, its low
allele frequency did not allow us to determine whether or not this mutation is exclusively asso-
ciated with ALS. Nonetheless, our genetic analyses implicate LSM12 as a risk factor for NCT-
relevant pathogenesis in ALS/FTD.
LSM12 posttranscriptionally up-regulates EPAC1 expression to sustain the
RAN gradient for NCT and suppress poly(GR) toxicity
To elucidate how LSM12 contributes to the establishment of a nucleocytoplasmic RAN gradi-
ent, we performed gene expression analyses using RNA sequencing. Given the role of LSM12
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in translation [55], we compared LSM12-dependent changes in total mRNAs with changes in
translating ribosome-associated mRNAs (Fig 5A, S6 Fig). Among genes that were differentially
expressed between control and LSM12-depleted cells, EPAC1 displayed low expression in
either RNA analyses of LSM12-depleted cells. Further independent analyses confirmed that
both EPAC1 transcript and EPAC1 protein were expressed at low levels in either LSM12-de-
pleted cells or LSM12-deleted cells compared with those in control cells (Fig 5B and 5C, S7A
Fig). To investigate how LSM12 up-regulates EPAC1 expression, we generated EPAC1 reporter
transgenes of which expression was transcriptionally driven by EPAC1 promoter or posttran-
scriptionally controlled by EPAC1 untranslated regions (UTRs) (S7B Fig). While the loss of
LSM12 function did not affect the EPAC1 promoter activity, we found that EPAC1 50 UTR was
necessary and sufficient for LSM12-dependent expression of the posttranscriptional EPAC1
Fig 4. An LSM12V135I mutant allele exhibits dominant-negative effects on the RAN gradient. (A) Overexpression of LSM12V135I mutant protein impairs NCT.
Control and LSM12KO cells were co-transfected with expression vectors for S-GFP and FLAG-tagged LSM12 (wild-type or LSM12V135I mutant). Transfected cells were
treated with 50-μM NaAsO2 or PBS (vehicle control) for 2 hours and then co-stained with anti-FLAG antibody (red) and Hoechst 33258 (blue) 48 hours after
transfection. (B) NCT of S-GFP reporter proteins was quantified as in Fig 2B. Two-way ANOVA detected significant interaction effects of arsenite treatment and LSM12
deletion on NCT only in FLAG-expressing cells (P = 0.0026). Data represent means ± SEM (n = 119–138 cells from 3 independent experiments). n.s., not significant;
���P< 0.001, as determined by Tukey post hoc test. (C) Overexpression of LSM12V135I mutant protein promotes the nuclear accumulation of poly(GR) granules.
SH-SY5Y cells were co-transfected with expression vectors for GFP-GR100 and FLAG-tagged LSM12 (wild-type or LSM12
V135I mutant) and then co-stained with anti-
FLAG antibody (red), anti-G3BP1 antibody (magenta), and Hoechst 33258 (blue) 48 hours after transfection. (D) The assemblies of poly(GR)-induced SGs and nuclear
poly(GR) granules were quantified as in Fig 1. Data represent means ± SEM (n = 19 confocal images obtained from 3 independent experiments; n = 279–327 GFP-GR100–
positive cells). n.s., not significant; �P< 0.05, ���P< 0.001, as determined by 1-way ANOVA with Dunnett post hoc test. (E) Overexpression of LSM12V135I mutant
protein disrupts the nucleocytoplasmic RAN gradient. Control and LSM12KO cells were transfected with an expression vector for FLAG-tagged LSM12 (wild-type or
LSM12V135I mutant) and then co-stained with anti-RAN antibody (red), anti-FLAG antibody (green), and Hoechst 33258 (blue) 48 hours after transfection. (F) The
nucleocytoplasmic RAN gradient was quantified as in Fig 2D. Data represent means ± SEM (n = 119–120 cells from 3 independent experiments). n.s., not significant;
���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc test. All underlying numerical values are available in S1 Data. ANOVA, analysis of variance; GFP,
green fluorescent protein; LSM12, like-Sm protein 12; SEM, standard error of the mean; N/C, nuclear to cytoplasmic; NCT, nucleocytoplasmic transport.
https://doi.org/10.1371/journal.pbio.3001002.g004
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reporters (Fig 5D, S7C Fig). These results thus validate that LSM12 acts as a posttranscriptional
activator of EPAC1.
EPAC1 has been shown to act as a cAMP sensor for the activation of RAP signaling on the
plasma membrane [75]. On the other hand, EPAC1 also localizes to the nuclear envelope and
associates with nucleoporin complexes containing RAN, RANGAP1, Ran-binding protein 2
(RANBP2; also known as NUP358), and importin β1 [75–77]. We thus hypothesized that the
action of EPAC1 in nucleoporin assembly or function might contribute to LSM12 effects on
Fig 5. LSM12 posttranscriptionally up-regulates EPAC1 expression to sustain the RAN gradient for NCT. (A) Fold changes in total transcript levels (x-axis) versus
translating ribosome-associated transcript levels (y-axis) in LSM12-depleted cells were assessed by RNA sequencing (n = 2 biological replicates; n = 10,856 transcripts)
and depicted as a scatter plot. (B) LSM12-depleted cells express low levels of EPAC1 transcript. Total RNA was prepared from controlshRNA and LSM12shRNA cells. The
abundance of each transcript was quantified by real-time RT-PCR and normalized to that of GAPDH. Relative mRNA levels in LSM12shRNA cells were then calculated by
normalizing to those in controlshRNA cells. Data represent means ± SEM (n = 3). �P< 0.05, ���P< 0.001, as determined by Student t test. (C) LSM12-depleted cells
express low levels of EPAC1 protein. The abundance of each protein was quantified as in Fig 1C. Data represent means ± SEM (n = 3). ��P< 0.01, as determined by
Student t test. (D) LSM12 depletion posttranscriptionally decreases EPAC1 expression via the 50 UTR. EPAC1 reporter plasmids encoding NLUC were generated as
depicted in S7B Fig. ControlshRNA and LSM12shRNA cells were co-transfected with each EPAC1 reporter and FLUC expression vector (normalizing control). Luciferase
reporter assays were performed 48 hours after transfection. NLUC activity was first normalized to FLUC activity per condition. Relative expression of each EPAC1
reporter in LSM12shRNA cells was then calculated by normalizing to the NLUC/FLUC value in controlshRNA cells. Data represent means ± SEM (n = 4). n.s., not
significant; �P< 0.05, as determined by Student t test. (E) EPAC1 overexpression restores the nucleocytoplasmic RAN gradient in LSM12-deleted cells. Control and
LSM12KO cells were transfected with an expression vector for FLAG or FLAG-tagged EPAC1 and then co-stained with anti-RAN antibody (red), anti-FLAG antibody
(green), and Hoechst 33258 (blue) 48 hours after transfection. (F) The nucleocytoplasmic RAN gradient was quantified as in Fig 2D. Data represent means ± SEM
(n = 103–107 cells from 3 independent experiments). n.s., not significant; ���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc test. (G) EPAC1
overexpression suppresses LSM12-deletion effects on the poly(GR)-induced disruption of NCT. Control and LSM12KO cells were co-transfected with different
combinations of expression vectors for S-tdT, GFP-GR100, and FLAG-tagged EPAC1 and then co-stained with anti-FLAG antibody (magenta) and Hoechst 33258 (blue)
48 hours after transfection. (H) NCT of S-tdT reporter proteins was quantified as in Fig 2B. Two-way ANOVA detected significant interaction effects of GFP-GR100 and
LSM12 deletion on NCT only in FLAG-expressing cells (P = 0.0018). Data represent means ± SEM (n = 123–153 cells from 3 independent experiments). n.s., not
significant; ���P< 0.001, as determined by Tukey post hoc test. All underlying numerical values are available in S1 Data. ANOVA, analysis of variance; EPAC1, exchange
protein directly activated by cyclic AMP 1; FLUC, firefly luciferase; GFP, green fluorescent protein; LSM12, like-Sm protein 12; N/C, nuclear to cytoplasmic; NCT,
nucleocytoplasmic transport; NLUC, Nano-luciferase; RNA-seq, RNA sequencing; RT-PCR, reverse transcription PCR; S-tdT, S-tdTomato; SEM, standard error of the
mean; shRNA, short hairpin; TRAP-seq, translating ribosome affinity purification sequencing.
https://doi.org/10.1371/journal.pbio.3001002.g005
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the RAN gradient and NCT. To test this possibility, we first examined if EPAC1 overexpres-
sion restored the RAN gradient in LSM12-deleted cells. Indeed, EPAC1 overexpression sub-
stantially suppressed the aberrant localization of RAN in the cytoplasm of LSM12-deleted cells,
while negligibly affecting the RAN gradient in control cells (Fig 5E and 5F). Consistent with
this rescue effect, EPAC1 overexpression suppressed loss-of-function effects of LSM12 on the
disruption of NCT induced by poly(GR) overexpression (Fig 5G and 5H). These data indicate
that EPAC1 is limiting for sustaining the RAN gradient and NCT in LSM12-deleted cells.
Next, we asked whether the loss of EPAC1 function would be sufficient to induce cellular
phenotypes observed with the loss of LSM12 function. To this end, we depleted endogenous
EPAC1 protein by transiently transfecting SH-SY5Y cells with small interfering RNA (siRNA)
targeting the EPAC1 transcript (S8A Fig). EPAC1 depletion indeed decreased the ratio of
nuclear to cytoplasmic RAN distribution regardless of poly(GR) overexpression (Fig 6A and
6B), mimicking the RAN phenotypes in LSM12-depleted or LSM12-deleted cells under basal
conditions. Moreover, we observed nonadditive disruption of the RAN gradient by EPAC1
depletion and LSM12 deletion (S8B Fig), further confirming that EPAC1 and LSM12 act in the
same pathway for sustaining a RAN gradient. ISRIB treatment failed to suppress the effects of
EPAC1 depletion on the RAN gradient (Fig 6A and 6B) and poly(GR)-induced disruption of
NCT (S8C and S8D Fig), consistent with an SG-independent role of LSM12 on the RAN gradi-
ent and NCT. Not surprisingly, EPAC1 depletion enhanced nuclear accumulation of poly(GR)
protein (Fig 6C and 6D) and increased the poly(GR)-expressing cell population harboring SGs
(S8E Fig). Consequently, nuclear membrane integrity was severely impaired by poly(GR) over-
expression in EPAC1-depleted cells in an ISRIB-insensitive manner (Fig 6E and 6F). Finally,
either heterozygosity of Epac deletion mutation [78] or RNA interference-mediated depletion
of EPAC exacerbated degeneration of Drosophila photoreceptor neurons overexpressing poly
(GR) protein (S9 Fig), revealing a conserved role of EPAC1 homologs in the poly(GR)-induced
pathogenesis.
Overexpression of LSM12 or EPAC1 rescues NCT-relevant pathologies in
ALS patient-derived neurons
Our genetic analyses of the loss-of-function phenotypes indicate that deficits in the LSM12-
EPAC1 pathway disrupt the RAN gradient, making the affected cells more susceptible to
genetic or environmental perturbations in NCT-related physiology. Nonetheless, we reasoned
that a neuroprotective function of this pathway would be better demonstrated if its up-regula-
tion could rescue ALS/FTD-relevant pathologies in the RAN gradient and NCT. We first
tested this possibility in SH-SY5Y cells transiently expressing poly(GR) protein. Indeed, over-
expression of LSM12 or EPAC1 significantly suppressed poly(GR)-induced disruption of the
RAN gradient (Fig 6G and 6H) and nuclear integrity (Fig 6I and 6J).
To validate the disease relevance of these findings, we employed induced pluripotent stem
cell (iPSC)-derived neurons from 3 C9ORF72-associated ALS patients (C9-ALS iPSNs). A pre-
vious study showed that all these C9-ALS iPSC lines (CS28, CS29, and CS52) had mutant
C9ORF72 alleles with approximately 800 hexanucleotide repeats [79]. In addition, an isogenic
control iPSC line (CS29-ISO) was established by the CRISPR/Cas9-mediated deletion of the
hexanucleotide repeat expansion in one of these C9-ALS iPSC lines (C9-ALS CS29) [80]. This
isogenic pair (CS29-ISO and C9-ALS CS29) accordingly served as a good resource to compare
any effects of the C9ORF72 hexanucleotide repeats and our lentiviral transgenes in the same
genetic background. Immunofluorescence analyses confirmed comparable neuronal differen-
tiation from CS29-ISO and C9-ALS CS29 iPSC lines (S10A Fig). Our experimental conditions
led to mixed neuronal cultures, including approximately 95% MAP2-positive (a neuronal
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Fig 6. EPAC1 suppresses poly(GR) toxicity relevant to NCT and nuclear integrity. (A) SH-SY5Y cells were transfected with controlsiRNA or EPAC1siRNA 24 hours
before transfecting with an expression vector for GFP or GFP-GR100. Transfected cells were co-stained with anti-RAN antibody (red), anti-G3BP1 antibody (magenta),
and Hoechst 33258 (blue) 72 hours after siRNA transfection. Where indicated, cells were treated with 2-μM ISRIB or DMSO (vehicle control) for 5 hours before antibody
staining. (B) The nucleocytoplasmic RAN gradient was quantified as in Fig 2D. Two-way ANOVA detected significant interaction effects of GFP-GR100 and ISRIB
treatment on the RAN gradient in controlsiRNA cells (P = 0.0008), but not in EPAC1siRNA cells (P = 0.4674 for EPAC1siRNA #1; P = 0.7870 for EPAC1siRNA #2); significant
interaction effects of GFP-GR100 and EPAC1 depletion on the RAN gradient regardless of ISRIB treatment (P< 0.0001 for both EPAC1siRNA in DMSO; P = 0.0327 for
EPAC1siRNA #1 in ISRIB; P = 0.0013 for EPAC1siRNA #2 in ISRIB). Data represent means ± SEM (n = 124–145 GFP–or GFP-GR100–positive cells from 3 independent
experiments). n.s., not significant; ���P< 0.001, as determined by Tukey post hoc test. (C) EPAC1 depletion facilitates the nuclear accumulation of poly(GR) protein.
SH-SY5Y cells were co-transfected with each siRNA and a GFP-GR100 expression vector as above. Transfected cells were co-stained with anti-G3BP1 antibody (red) and
Hoechst 33258 (blue) at the indicated time points after plasmid DNA transfection. (D) The assembly of nuclear poly(GR) granules was quantified as in Fig 1. Data
represent means ± SEM (n = 18–19 confocal images obtained from 3 independent experiments; n = 366–413 GFP-GR100–positive cells). ��P< 0.01, ���P< 0.001, as
determined by Student t test. (E) EPAC1 depletion exacerbates the poly(GR)-induced disruption of the nuclear lamina. SH-SY5Y cells were co-transfected with each
siRNA and a GFP-GR100 expression vector, treated with 2-μM ISRIB or DMSO (vehicle control) and then co-stained with anti-lamin B1 antibody (red), anti-G3BP1
antibody (magenta), and Hoechst 33258 (blue) as described above. Yellow arrows indicate GFP-GR100–positive cells with severe nuclear lamina disruption. (F) The
abnormal nuclear laminar morphology was quantified as in Fig 3E. Two-way ANOVA detected significant interaction effects of GFP-GR100 and EPAC1 depletion on the
nuclear integrity regardless of ISRIB treatment (P< 0.0001 for both DMSO and ISRIB). Data represent means ± SEM (n = 15 confocal images obtained from 3
independent experiments; n = 313–545 GFP–or GFP-GR100–positive cells). n.s., not significant; ���P< 0.001, as determined by Tukey post hoc test. (G, H)
Overexpression of LSM12 or EPAC1 suppresses the poly(GR)-induced disruption of the RAN gradient. SH-SY5Y cells were co-transfected with different combinations of
expression vectors for FLAG-tagged LSM12, FLAG-tagged EPAC1, and GFP-GR100. Transfected cells were co-stained with anti-RAN antibody (red), anti-FLAG antibody
(magenta), and Hoechst 33258 (blue). The nucleocytoplasmic RAN gradient was quantified as in Fig 2D. Two-way ANOVA detected significant interaction effects of
GFP-GR100 with LSM12 or EPAC1 overexpression on the RAN gradient (P< 0.0001 for both). Data represent means ± SEM (n = 101–109 GFP–or GFP-GR100–positive
cells from 3 independent experiments). n.s., not significant; ���P< 0.001, as determined by Tukey post hoc test. (I, J) Overexpression of LSM12 or EPAC1 suppresses the
poly(GR)-induced disruption of the nuclear lamina. Yellow arrows indicate GFP-GR100–positive cells with severe nuclear lamina disruption. Magenta arrows indicate cells
overexpressing LSM12-FLAG or EPAC1-FLAG protein. The abnormal morphology of the nuclear lamina was quantified as in Fig 3E. Data represent means ± SEM
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marker), 70% ChAT-positive (cholinergic neurons), and 25% to 30% HB9-positive cells
(motor neurons), as reported previously [81]. Moreover, iPSNs from C9-ALS CS29, but not
their isogenic control iPSNs, displayed poly(GR) aggregates at readily detectable levels (S10B
Fig).
We further found that the abundance of LSM12 and EPAC1 proteins was significantly
decreased in C9-ALS iPSNs from all 3 patients, compared to control iPSNs (Fig 7A). Quantita-
tive transcript analyses revealed lower levels of LSM12 and EPAC1 mRNAs in C9-ALS iPSNs
(Fig 7B). While the underlying mechanism remains to be determined, we hypothesized that
this down-regulation of the LSM12-EPAC1 pathway might be limiting for NCT-relevant
pathologies in C9-ALS iPSNs [33,37,39,81]. A significant reduction (approximately 35%) in
the nuclear to cytoplasmic ratio of RAN protein in C9-ALS iPSNs was partially, but signifi-
cantly, rescued by lentiviral overexpression of LSM12 or EPAC1 (Fig 7C, 7D, S11A Fig). We
confirmed that their overexpression negligibly affected neuronal differentiation efficiency per
se (S11B and S11C Fig). TDP-43 pathogenesis is the most prominent feature in ALS/FTD, and
it has been shown that the loss of nuclear function, as well as the gain of cytoplasmic function,
contribute to the underlying neurodegenerative processes [63,82–87]. Given that the nuclear
import of TDP-43 is RAN dependent [85,86], we further assessed the neuroprotective effects
of the LSM12-EPAC1 pathway on the cytoplasmic mislocalization of TDP-43 in C9-ALS iPSNs
[37]. Consistent with the RAN gradient rescue, overexpression of LSM12 or EPAC1 sup-
pressed TDP-43 mislocalization to the cytoplasm of C9-ALS iPSNs (Fig 7E and 7F). On either
the RAN gradient or TDP-43 mislocalization, LSM12V135I overexpression exhibited domi-
nant-negative effects in control iPSNs (Fig 7 C–F).
Finally, we asked whether the transgenic enhancement of the LSM12-EPAC1 pathway
could alleviate neurodegenerative phenotypes in C9-ALS iPSNs. Consistent with previous
observations [88,89], the percentages of neurons expressing cleaved caspase-3 were substan-
tially elevated in C9-ALS iPSNs from all 3 patients (Fig 7G and 7H, S12 Fig), likely indicating
their pathogenic activation of the proapoptotic pathway. We further found that overexpression
of LSM12 or EPAC1 partially, but significantly, suppressed the caspase-3 activation for apopto-
sis in all 3 C9-ALS iPSN lines (Fig 7G and 7H, S12 Fig). Taken together, these lines of evidence
convincingly support our conclusion that LSM12 and EPAC1 constitute a neuroprotective
pathway for sustaining the RAN gradient and NCT in the pathophysiology of C9ORF72-asso-
ciated ALS/FTD.
The LSM12-EPAC1 pathway promotes RAN-importin β1 loading onto
RANBP2-RANGAP1 at the nuclear pore complex
Previous studies have suggested that RANBP2-RANGAP1 recruits the RAN-importin β1 com-
plex to the cytoplasmic side of the nuclear pore complex, facilitating its recycling across the
nuclear membrane [90,91]. RAN-GTP actually promotes the association of importin β1 with
RANBP2, whereas RAN-GDP loses its affinity for both proteins [90,92,93]. Moreover, EPAC1
associates preferentially with RAN-GTP, and EPAC1 overexpression stabilizes the association
between RAN and RANBP2 [75]. We thus hypothesized that the LSM12-EPAC1 pathway
might control the dynamic assembly of the RAN-associating protein complex, thereby contrib-
uting to the establishment of the nucleocytoplasmic RAN gradient. To examine this possibility,
(n = 11–19 confocal images obtained from 3 independent experiments; n = 235–508 GFP–or GFP-GR100–positive cells). n.s., not significant; �P< 0.05, ���P< 0.001, as
determined by 2-way ANOVA with Tukey post hoc test. All underlying numerical values are available in S1 Data. ANOVA, analysis of variance; EPAC1, exchange protein
directly activated by cyclic AMP 1; GFP, green fluorescent protein; ISRIB, integrated stress response inhibitor; LSM12, like-Sm protein 12; N/C, nuclear to cytoplasmic;
NCT, nucleocytoplasmic transport; SEM, standard error of the mean; siRNA, small interfering RNA.
https://doi.org/10.1371/journal.pbio.3001002.g006
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Fig 7. Overexpression of LSM12 or EPAC1 rescues NCT-relevant pathologies in C9-ALS patient-derived neurons. (A) C9-ALS iPSNs express low levels of LSM12
and EPAC1 proteins. C9-ALS iPSNs (CS28, CS29, and CS52) and control iPSNs (CS0, CS29-ISO, CS4) were harvested 21 days after neuronal differentiation from NPCs.
Total cell extracts from 3-week-old iPSNs were resolved by SDS-PAGE and immunoblotted with anti-LSM12, anti-EPAC1, and anti-tubulin (loading control) antibodies.
The abundance of each protein was quantified as in Fig 1C. Error bars indicate SEM (n = 3 independent differentiation experiments). �P< 0.05, ��P< 0.01, as
determined by 1-way ANOVA with Dunnett post hoc test. (B) C9-ALS iPSNs express low levels of LSM12 and EPAC1 transcripts. Total RNA was prepared from 3-week-
old iPSNs, and the abundance of each transcript was quantified as in Fig 5B. Data represent means ± SEM (n = 3 independent differentiation experiments). n.s., not
significant; �P< 0.05, as determined by 1-way ANOVA with Dunnett post hoc test. (C, D) Overexpression of LSM12 or EPAC1 rescues the RAN gradient in C9-ALS
iPSNs. NPCs from C9-ALS iPSCs (CS29) and their isogenic control cells (CS29-ISO) were transduced with individual recombinant lentiviruses that express the indicated
FLAG-tagged proteins along with a GFP reporter. iPSNs were fixed 21 days after neuronal differentiation from NPCs and co-stained with anti-RAN antibody (red), anti-
MAP2 antibody (magenta), and Hoechst 33258 (blue). The nucleocytoplasmic RAN gradient was quantified as in Fig 2D. Two-way ANOVA detected significant
interaction effects of C9-ALS and lentiviral overexpression on the RAN gradient (P = 0.0051 for LSM12; P = 0.0066 for LSM12V135I; P = 0.0041 for EPAC1). Data
represent means ± SEM (n = 100–105 GFP–positive cells from 4 independent differentiation experiments). n.s., not significant; �P< 0.05, ��P< 0.01, ���P< 0.001, as
determined by Tukey post hoc test. (E, F) Overexpression of LSM12 or EPAC1 suppresses the pathogenic mislocalization of TDP-43 in the cytoplasm of C9-ALS iPSNs.
Three-week-old iPSNs (CS29-ISO and C9-ALS CS29) were co-stained with anti-TDP-43 antibody (red), anti-MAP2 antibody (magenta), and Hoechst 33258 (blue). The
relative distribution of endogenous TDP-43 proteins was quantified similarly as above. Two-way ANOVA detected significant interaction effects of C9-ALS and lentiviral
overexpression on the RAN gradient (P = 0.0154 for LSM12; P = 0.0120 for EPAC1). Data represent means ± SEM (n = 102–104 GFP–positive cells from 4 independent
differentiation experiments). n.s., not significant; �P< 0.05, ��P< 0.01, ���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc test. (G, H) Overexpression
of LSM12 or EPAC1 suppresses caspase-3 activation in C9-ALS iPSNs. Three-week-old iPSNs (CS29-ISO and C9-ALS CS29) were co-stained with anti-cleaved caspase-3
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we performed a series of immunoprecipitation (IP) experiments and compared the biochemi-
cal composition of RAN-containing protein complexes in different genetic settings and phar-
macological conditions.
As expected, an anti-RANBP2 antibody co-purified RAN, importin β1, and SUMOylated
RANGAP1, together with RANBP2, from control cell extracts (Fig 8A). LSM12 deletion
enhanced the association of SUMOylated RANGAP1 with RANBP2 while dissociating RAN
and importin β1 from the RANBP2-RANGAP1 complex. Similar results were obtained by
reciprocal IP using an anti-RANGAP1 antibody (S13A Fig). Pretreatment with a cell-perme-
able cAMP analog (8-pCPT-2-O-Me-cAMP-AM/007-AM) neither affected the assembly of
wild-type RAN-associating protein complex nor rescued LSM12-deletion phenotypes (S13B
Fig). EPAC1 activation by cAMP thus is unlikely involved in these biochemical interactions.
Similar IP experiments in EPAC1-depleted cells further revealed that EPAC1 depletion caused
dissociation of RAN and importin β1 from the RANBP2-RANGAP1 complex (S13C and S13D
Fig), consistent with LSM12-deletion effects.
In either case, the enrichment of endogenous EPAC1 protein in RANBP2-RANGAP1
immunoprecipitates was not readily detectable, possibly owing to the abundance of free
EPAC1 proteins in the cytoplasm compared with those associated with the RANBP2-RAN-
GAP1 complex at the nuclear pore. Affinity purification of FLAG-tagged EPAC1 protein
indeed confirmed its association with RANGAP1, RANBP2, importin β1, and RAN (Fig 8B).
Moreover, overexpression of the FLAG-tagged EPAC1 protein restored the assembly of RAN-
associating protein complexes in LSM12-deleted cells, consistent with its rescue effects on the
RAN gradient and NCT. These results indicate that the LSM12-EPAC1 pathway promotes the
association of RAN and importin β1 with the RANBP2-RANGAP1 complex. Stronger interac-
tions between RANBP2 and RANGAP1 in LSM12-deleted or EPAC1-depleted cells suggest
their competitive interaction with RAN and importin β1.
RAN overexpression mitigates EPAC1-depletion effects on poly(GR)
toxicity
To determine whether the status of RAN-bound GTP hydrolysis contributes to EPAC1 effects
on the assembly of RAN-associating protein complexes, we added a hydrolysis-resistant GTP
analog (GTPγS) to cell extracts before IP. The assembly of the RANBP2-associating protein
complex was insensitive to GTPγS in control cells (Fig 8C). By contrast, preincubation of
GTPγS with extracts from EPAC1-depleted cells restored the association of RAN and importin
β1 with the RANBP2-RANGAP1 complex to control cell levels (Fig 8C). These results indicate
that RAN-GTP is specifically limiting for the stable association of RAN-importin β1 with
RANBP2-RANGAP1 in EPAC1-depleted cells. Given that the intracellular concentration of
GTP is approximately 10-fold higher than that of GDP, we hypothesized that overexpression
of wild-type RAN proteins would supply extra RAN-GTP in EPAC1-depleted cells and thereby
rescue cellular phenotypes relevant to the lack of RAN-GTP. We indeed found that RAN over-
expression substantially suppressed the formation of nuclear GR granules (Fig 8D) and poly
(GR)-induced disruption of the nuclear membrane in EPAC1-depleted cells (Fig 8E and 8F),
while modestly inhibiting poly(GR) effects in control cells. RAN overexpression also
antibody (red), anti-MAP2 antibody, and Hoechst 33258 (blue). The relative percentages of iPSNs expressing cleaved caspase-3 were averaged from 15 confocal images of
random fields of interest per condition (n = 771–1,129 GFP-positive cells from 3 independent differentiation experiments). Data represent means ± SEM. n.s., not
significant; ���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc test. All underlying numerical values are available in S1 Data. ANOVA, analysis of
variance; ATXN2, ataxin-2; C9-ALS, C9ORF72-associated amyotrophic lateral sclerosis; EPAC1, exchange protein directly activated by cyclic AMP 1; GFP, green
fluorescent protein; LSM12, like-Sm protein 12; N/C, nuclear to cytoplasmic; NCT, nucleocytoplasmic transport; NPC, neural progenitor cell; SEM, standard error of the
mean.
https://doi.org/10.1371/journal.pbio.3001002.g007
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suppressed EPAC1-depletion effects on poly(GR)-induced disruption of NCT, although it had
negligible effects in control cells (S14A and S14B Fig). Taken together, these data demonstrate
that the LSM12-EPAC1 pathway facilitates the nucleocytoplasmic recycling of RAN-GTP and
thereby confers cellular resistance to poly(GR)-related pathogenic processes.
Discussion
Identification of noncanonical translation products from hexanucleotide repeat expansions in
the C9ORF72 locus and their impact on specific aspects of cell physiology have advanced our
understanding of the pathogenesis of ALS/FTD [22,23]. C9ORF72-derived poly(GR) proteins
assemble into distinct intracellular compartments, yet they also induce the formation of SGs
[94]. Nonfunctional sequestration of NCT-related factors into SGs has been proposed as a key
Fig 8. EPAC1 depletion limits RAN-GTP availability for assembly of the RAN-associating nuclear pore complex and suppression of poly(GR) toxicity. (A) LSM12
deletion dissociates RAN and importin β1 from the RANBP2-RANGAP1 complex. Soluble extracts from control and LSM12KO cells were immunoprecipitated with
control IgG or anti-RANBP2 antibody. Purified IP complexes were resolved by SDS-PAGE and immunoblotted with specific antibodies (left). Asterisks indicate
SUMOylated RANGAP1. Input, 4.5% of soluble extracts used in each IP. (B) EPAC1 overexpression restores the assembly of RAN-associating nuclear pore complex in
LSM12-deleted cells. Control and LSM12KO cells were transfected with FLAG or EPAC1-FLAG expression vector. Soluble extracts were prepared 48 hours after
transfection and then immunoprecipitated with anti-FLAG antibody. (C) The hydrolysis-resistant GTP analog, GTPγS, blocks the dissociation of RAN and importin β1
from the RANBP2-RANGAP1 complex in EPAC1-depleted cells. Where indicated, soluble cell extracts were preincubated with 0.1 mM GTPγS or DMSO (vehicle
control) at 25˚C for 30 minutes before IP. (D) RAN overexpression suppresses the nuclear assembly of poly(GR) granules. SH-SY5Y cells were co-transfected with siRNA,
GFP-GR100, and RAN-FLAG expression vectors, as in Fig 6A. Transfected cells were co-stained with anti-lamin B1 antibody (red), anti-FLAG antibody (magenta), and
Hoechst 33258 (blue) 48 hours after plasmid DNA transfection. The assembly of nuclear poly(GR) granules was quantified similarly as in Fig 1. Data represent
means ± SEM (n = 15–17 confocal images obtained from 3 independent experiments; n = 280–471 GFP-GR100–positive cells). n.s., not significant; �P< 0.05, ��P< 0.01,
���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc test. (E, F) RAN overexpression suppresses the poly(GR)-induced disruption of the nuclear lamina.
Yellow arrows indicate GFP-GR100–positive cells with severe nuclear lamina disruption. Magenta arrows indicate cells overexpressing RAN-FLAG protein. The abnormal
morphology of the nuclear lamina was quantified as in Fig 3E. Data represent means ± SEM (n = 16–17 confocal images obtained from 3 independent experiments;
n = 325–547 GFP–or GFP-GR100–positive cells). n.s., not significant; ��P< 0.01, ���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc test. All underlying
numerical values are available in S1 Data. ANOVA, analysis of variance; EPAC1, exchange protein directly activated by cyclic AMP 1; GFP, green fluorescent protein; IP,
immunoprecipitation; LSM12, like-Sm protein 12; SEM, standard error of the mean; siRNA, small interfering RNA.
https://doi.org/10.1371/journal.pbio.3001002.g008
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mechanism for the NCT deficits implicated in ALS/FTD [33]. This has been validated by mod-
ifier screens in yeast and Drosophila genetic models [37,39,95], indicating strong conservation
of their pathogenic mechanism. Mutations in ATXN2, one of these genetic modifiers, are
indeed associated with ALS [42], and it has been shown that ATXN2 facilitates neurodegenera-
tion, in part, by promoting SG formation [33,43]. As expected, we found that ATXN2 and
ATXN2-associated LSM12 make a nonadditive contribution to the dynamic assembly of SGs.
Unexpectedly, however, we discovered opposing effects of LSM12 and its posttranscriptional
downstream effector, EPAC1, on neurodegeneration. The LSM12-EPAC1 pathway assembles
the RAN-associating nuclear pore complex and establishes the nucleocytoplasmic RAN gradi-
ent, thereby antagonizing the effects of poly(GR) protein on NCT and nuclear membrane
integrity. Our definition of the neuroprotective LSM12-EPAC1 pathway was further supported
by its suppression of NCT-relevant pathologies and caspase-3 activation for apoptosis in
C9-ALS iPSNs.
We propose that EPAC1 mediates the immediate recycling of nuclear RAN-GTP by sup-
porting the stable association of RAN-importin β1 with RANBP2-RANGAP1 at the cyto-
plasmic side of the nuclear pore complex (S15 Fig). An EPAC1 deficiency, on the other hand,
would allow nuclear RAN-GTP to diffuse out of the nuclear pore and further localize in the
cytoplasm. The cytoplasmic RANGAP complex (e.g., RANBP1-RANGAP) then mediates
RAN-GTP hydrolysis [96], thereby delaying the nuclear import of RAN-GDP by nuclear
transport factor 2 (NTF2) [97–99] and limiting the regeneration of RAN-GTP from
RAN-GDP by nuclear RCC1/RANGEF. RAN overexpression may increase the total flux of
RAN recycling and elevate the local concentration of RAN at the nuclear pore complex. Con-
sequently, RAN overexpression could facilitate NTF2-dependent nuclear import of RAN-GDP
in EPAC1-depleted cells, partially restore nucleocytoplasmic RAN gradient, and compensate
for the loss of EPAC1 function in the assembly of RAN-associating protein complexes at the
nuclear pore. This model may explain our observation that RAN overexpression rescues
EPAC1-depletion phenotypes in NCT and poly(GR) toxicity. Notably, RAN overexpression
similarly suppresses the cytotoxic effects of mutant huntingtin through a mechanism that also
involves disruption of the RAN gradient and NCT [72].
When transiently expressed in cell culture, poly(GR) proteins display heterogeneity in their
subcellular expression patterns, ranging from a uniform distribution in the cytoplasm to
nucleolar localization [25,30,33]. We found that cytoplasmic poly(GR) protein accumulated
gradually in subnuclear compartments, a localization pattern that strongly correlated with the
loss of nuclear integrity, as assessed by invaginations of the nuclear lamina. Given the active
role of RAN in nucleating formation of the nuclear envelope [100,101] and assembly of the
nuclear pore complex [102,103], we speculate that poly(GR)-induced disruption of the RAN
gradient feeds forward to increase the permeability of the nuclear envelope, allowing more
cytoplasmic poly(GR) protein to enter the nucleus and trigger nuclear pathogenesis, including
nucleolar stress [25,26,30,31]. Consistent with this idea, we showed that RAN overexpression
was sufficient to suppress the nuclear translocation of cytoplasmic poly(GR) proteins and sus-
tain nuclear integrity in poly(GR)-expressing cells. This aspect of RAN function is relevant to
the chromatin association of RAN and RCC1/RANGEF, which intrinsically cues the relative
location of nuclei and generates the RAN-GTP gradient during mitosis [104,105]. Nonetheless,
it remains to be determined if poly(GR)-induced disruption of the RAN gradient comparably
affects the functionality of the nuclear envelope in postmitotic cells since some conflicting
observations were made on the nuclear envelope invaginations between C9-ALS iPSNs and
postmortem cortical tissue from C9ORF72-associated ALS patients [106].
Genetic mutations in nuclear lamin genes cause a group of rare genetic disorders, collec-
tively called laminopathies [107]. For instance, premature aging in Hutchinson–Gilford
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progeria syndrome (HGPS), caused by a lamin A/C mutation, manifests as cytological defects
in the nuclear envelope and heterochromatin formation [108–110]. Lamin A/C mutations,
including the pathogenic allele observed in HGPS, lead to disruption of the RAN gradient and
NCT [111–114]. These mutant phenotypes appear to be mediated by loss of heterochromatin
since genetic or pharmacological inhibition of heterochromatin formation by histone methyl-
transferases is sufficient to disrupt the RAN gradient and NCT [115]. Given our observation
that poly(GR)-induced loss of nuclear integrity is rescued by RAN overexpression, these find-
ings indicate possible interdependence among nuclear envelop integrity, heterochromatin for-
mation, and the RAN gradient. Interestingly, loss of heterochromatin formation and nuclear
lamina invaginations have been implicated in ALS/FTD-related pathogenic processes in a
mouse model [116]. An additional layer of homology is likely present between HGPS and
ALS/FTD, given that deficits in the nuclear import of DNA-repairing factors (e.g., ataxia-telan-
giectasia mutated kinase) may explain their common pathogenesis, which involves DNA dam-
age-induced cell death [89,115,117–119].
The nuclear pore complex is exceptionally long lived in postmitotic cells [120,121], and its
relevant function, such as NCT and nuclear integrity, declines with aging [110,122,123].
Emerging evidence indicates that cellular pathogeneses underlying distinct neurodegenerative
diseases, including ALS/FTD, Alzheimer’s disease, and Huntington’s disease, may converge on
the disruption of NCT [71–73,124,125]. Given our findings that EPAC1 acts as a gatekeeper in
the vicinity of nuclear pores to facilitate RAN recycling and sustain robust NCT, the posttran-
scriptional circuit of LSM12-EPAC1 would enrich the repertoire of antiaging molecular path-
ways that have evolved on fundamental cellular physiology.
Materials and methods
Cell culture
Human neuroblastoma SH-SY5Y and human embryonic kidney 293T cells were cultured in
Dulbecco’s Modified Eagle Medium (HyClone, Logan, Utah, United States of America) sup-
plemented with 10% fetal bovine serum and 1% antibiotics and maintained at 37˚C in a
humidified incubator with 95% air and 5% CO2. Plasmid DNA and siRNA were transiently
transfected using polyethylenimine [126] and Lipofectamine RNAiMAX transfection reagent
(Thermo Fisher Scientific, Waltham, Massachusetts, USA), respectively, according to the man-
ufacturer’s instructions. C9-ALS iPSC lines (CS28iALS, CS29iALS, and CS52iALS) and control
iPSC lines (CS0YX7iCTR, CS29iALS-ISO, and CS4NWCiCTR) were obtained from the
Cedars-Sinai iPSC Core. iPSCs were cultured on Matrigel-coated plates (Corning, Corning,
New York, USA) in mTeSR1 medium (STEMCELL Technologies, Vancouver, British Colum-
bia, Canada) in a humidified incubator with 95% air and 5% CO2 with daily media changes.
Motor neuron differentiation from iPSCs was induced, as described previously [81]. Where
indicated, neural progenitor cells (NPCs) were transduced with concentrated aliquots of
recombinant lentiviruses in the presence of 5 μg/ml polybrene for 6 hours to overexpress
LSM12 or EPAC1. iPSNs were harvested 21 days after neuronal differentiation from NPC and
subsequently analyzed.
Drosophila melanogaster
Flies were raised on standard cornmeal–yeast–agar medium (5.4% cornmeal, 1.3% yeast, 0.7%
soy flour, 0.4% agar, 4.2% starch syrup, 0.4% propionic acid, and 0.8% methyl 4-hydroxy-
benzoate) at 25˚C. UAS-poly-GR.PO-36 (BL58692), Epac deletion mutant (EpacΔ1/EpacΔ3,
BL78799), and UAS-Epac RNAi (v43444, v110077) lines were obtained from the Bloomington
Drosophila Stock Center and Vienna Drosophila Resource Center.
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DNA constructs
The nucleotide sequences for LSM12 and ATXN2 shRNAs were selected from a predesigned
library (Dharmacon, Lafayette, Colorado, USA). A control shRNA harbored a nucleotide
sequence (50-TCC TAA GGT TAA GTC GCC CTC-30) that did not target any mammalian
transcripts. Oligonucleotides encoding each shRNA were synthesized (Macrogen, Seoul,
Korea) and subcloned into pLKO.1 (a gift from B. Weinberg; Addgene plasmid #8453) for the
production of recombinant lentiviruses. The nucleotide sequences for EPAC1 siRNAs were
similarly selected from the predesigned library (Dharmacon). EPAC1 siRNAs and non-target-
ing control siRNA (50-CCU CGU GCC GUU CCA UCA GGU AGU U-30) were synthesized
(Genolution, Seoul, Korea), dissolved in PBS, and stored at −20˚C before use. A small guide
RNA (sgRNA) sequence (50-GAC GTG AGT TGG GAT CGG AG-30) for the CRISPR/Cas9-
mediated deletion of the LSM12 locus was designed using CHOPCHOP (https://chopchop.rc.
fas.harvard.edu). The oligonucleotide encoding LSM12 sgRNA was synthesized (Macrogen)
and subcloned into pRGEN-U6-sgRNA and pHRS (ToolGen, Seoul, Korea) for the expression
of LSM12 sgRNA and the hygromycin B-resistance reporter gene, respectively. Full-length
cDNAs encoding ATXN2, EPAC1, LSM12, or RAN proteins were PCR-amplified from
pcDNA6-ATXN2-22Q (a gift from A. Gitler), pEYFP-N3-EPAC1 (a gift from X. Cheng;
Addgene plasmid #113110) or SH-SY5Y cDNA samples, respectively, and then subcloned into
a modified pcDNA3.1 (pcDNA-3xnF) for the expression of carboxyl-terminal triple-FLAG
fusion proteins. Poly(GR)-encoding cDNA (a gift from D. Ito) was subcloned into a modified
pcDNA3.1 (pcDNA-GFP) vector for the expression of N-terminal GFP fusion proteins.
RPL10A-encoding cDNA was PCR-amplified from SH-SY5Y cDNA samples and subcloned
into a modified pcDNA-GFP vector containing a hygromycin B-resistance gene for the selec-
tion of cells stably expressing N-terminally GFP-fused RPL10A proteins. Subregions of the
EPAC1 locus were PCR-amplified from SH-SY5Y genomic DNA samples. The DNA frag-
ments corresponding to EPAC1 50 UTR or 30 UTR were subcloned into a modified pcDNA 3.1
(pcDNA-NLUC) vector for the expression of NLUC-encoding UTR reporter transcripts. The
DNA fragment corresponding to an EPAC1 promoter region was subcloned into a modified
pGL2 basic (pGL2-NLUC) vector for the NLUC reporter expression by the EPAC1 promoter
activity. FLUC-encoding cDNA was subcloned into pcDNA3.1 for the expression of a normal-
izing control reporter along with the NLUC reporters. S-GFP was a gift from M.S. Hipp [64].
S-tdT-encoding cDNA (a gift from J. D. Rothstein) was subcloned into pcDNA3.1. Lentiviral
vectors for overexpression of LSM12 or EPAC1 were constructed by the Gateway cloning
pENTR-Ubiquitin C promoter (Addgene plasmid #45959) and modified pENTR4-FLAG entry
vector (Addgene plasmid #17424) harboring either LSM12 or EPAC1 cDNA into
pCWX-DEST destination vector (Addgene plasmid #45957).
Production of recombinant lentiviruses and establishment of stable cell
lines
The 293T cells were co-transfected with viral packaging plasmids (ViraPower Lentiviral Pack-
aging Mix; Invitrogen, Carlsbad, California, USA) and third-generation pLKO.1 lentiviral vec-
tor encoding control, LSM12, or ATXN2 shRNA. Cell culture medium containing
recombinant lentiviruses was harvested 48 and 72 hours after transfection. SH-SY5Y cells were
then incubated with the lentiviral medium for 48 hours. Stably infected cells were selected by
replacing fresh media containing 1 μg/ml puromycin every 3 days for 2 weeks to establish a
stable cell line. Lentiviral particles for LSM12 or EPAC1 overexpression were produced simi-
larly as above and concentrated by ultracentrifugation at 25,000 rpm for 2 hours at 4˚C.
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Establishment of an LSM12-knockout (LSM12KO) cell line by CRISPR/
Cas9-mediated deletion
SH-SY5Y cells were co-transfected with pRGEN-Cas9-CMV, pRGEN-U6-LSM12 sgRNA, and
pHRS-LSM12 sgRNA reporter. Reporter-edited cells were selected by culturing in medium
containing 500 μg/ml hygromycin B for 2 weeks. Individual colonies were manually picked
and seeded into 12-well plates containing hygromycin B-free media to establish independent
cell lines. LSM12 expression in each cell line was analyzed by immunoblotting total cell
extracts with an anti-LSM12 antibody. Cell lines lacking detectable LSM12 expression were
further analyzed, whereas those showing LSM12 expression comparable to that of parental
cells served as controls.
Immunofluorescence assay
SH-SY5Y cells were grown on coverslips and then fixed in phosphate-buffered saline (PBS)
containing 3.7% formaldehyde at 25˚C for 15 minutes. NPCs were seeded on Matrigel-coated
coverslips. Twenty-one days after neuronal differentiation from NPC, iPSNs were fixed simi-
larly as above. After 2 washes with PBS, fixed cells were permeabilized with PBS containing
0.1% Triton X-100 (PBS-T) at 4˚C for 15 minutes, followed by 2 washes with PBS. Permeabi-
lized cells were blocked with PBS-T containing 1% bovine serum albumin at 25˚C for 30 min-
utes and then incubated with primary antibodies diluted in blocking buffer containing 0.05%
sodium azide at 4˚C for 1 day. The primary antibodies used in immunostaining were mouse
anti-RAN (1:1,000; Santa Cruz Biotechnology, Santa Cruz, California, USA), mouse anti-
G3BP1 (1:2,000; Santa Cruz Biotechnology), mouse anti-FLAG (1:2,000; Sigma-Aldrich,
St. Louis, Missouri, USA), rabbit anti-lamin B1 (1:1,000; Proteintech, Chicago, Illinois, USA),
rabbit anti-G3BP1 (1:2,000; Proteintech), mouse anti-PABPC1 (1:2,000; Santa Cruz Biotech-
nology), rabbit anti-ATXN2 (1:2,000; Proteintech), guinea pig anti-MAP2 (1:1,000; Synaptic
System, Goettingen, Germany), mouse anti-HB9 (1:1,000; Developmental Studies Hybridoma
Bank, Iowa City, Iowa, USA), and rabbit anti-ChAT (1:1,000; Proteintech), rabbit anti-polyGR
(1:250; Proteintech), rabbit anti-TDP43 (1:1,000; Proteintech), and rabbit anti-cleaved cas-
pase-3 (1:400; Cell Signaling Technology, Beverly, Massachusetts, USA). After incubation with
primary antibodies, cells were washed twice with PBS-T for 5 minutes each and then incubated
at 4˚C for 1 day with secondary antibodies diluted 1:600 in PBS-T. Species-specific Alexa Flour
488-, 594-, or 647-conjugated anti-IgG antibodies were used as secondary antibodies for
immunostaining (Jackson ImmunoResearch Laboratories, West Grove, Pennsylvania, USA).
Nuclei were visualized by staining with Hoechst for 5 minutes, followed by washing twice with
PBS-T. Stained samples were slide-mounted in VECTASHIELD antifade mounting medium
(Vector Laboratories, Burlingame, California, USA).
Quantitative image analysis
Several fields of interest were randomly selected from each imaging sample, and their confocal
images were individually obtained using an FV1000 microscope (Olympus, Tokyo, Japan)
with identical imaging settings. The fluorescence intensities of confocal images were quantified
using ImageJ software. For SG analysis, G3BP-positive cytoplasmic inclusions with fluores-
cence intensities above a threshold were unbiasedly scored as SGs using ImageJ. The total
numbers of cells, SG-positive cells and SGs per field, as well as the diameter of individual SGs,
were measured as described previously [127]. For nuclear poly(GR) granule analysis, the per-
centage of cells positive for nuclear poly(GR) granules per field and the number of nuclear
poly(GR) granules per cell were manually scored. The relative distribution of S-GFP, S-tdT,
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TDP-43, or RAN protein between nucleus and cytoplasm (N/C ratio) was quantified by calcu-
lating the ratio of nuclear to cytoplasmic fluorescence from each reporter protein, anti-TDP-
43 or anti-RAN antibody staining per cell, as described previously [64,128].
Quantitative RNA analysis
Total RNA was purified using the TRIzol reagent (Thermo Fisher Scientific) and digested with
DNase I according to the manufacturer’s instructions (Promega, Madison, Wisconsin, USA).
DNase I was subsequently removed by phenol–chloroform extraction. RNA samples were fur-
ther purified by ethanol precipitation and reverse-transcribed using M-MLV reverse transcrip-
tase (Promega) with random hexamers. cDNA samples were quantitatively analyzed using
SYBR Green-based Prime Q-Mastermix (GeNet Bio, Nonsan, Korea) and gene-specific prim-
ers on a LightCycler 480 real-time PCR system (Roche, Basel, Switzerland).
Luciferase reporter assay
SH-SY5Y cells on 12-well plates were co-transfected with 100 ng of EPAC1 NLUC reporter
plasmid and 100 ng of FLUC control plasmid. Transfected cells were harvested 48 hours after
transfection and lysed for luciferase assays using a Nano-Glo Dual Luciferase Assay kit (Pro-
mega) according to the manufacturer’s instructions. Luminescence from each cell lysate was
measured using a GloMax Navigator microplate luminometer (Promega).
Translating ribosome affinity purification (TRAP)
TRAP was performed as described previously [129] with minor modifications. Briefly,
SH-SY5Y cells stably expressing GFP-RPL10A were collected and lysed in a lysis buffer (20
mM HEPES-KOH pH 7.4, 150 mM KCl, 10 mM MgCl2, 1%(v/v) NP-40, 100 μg/ml cyclohexi-
mide, 1 mM dithiothreitol [DTT], 1 mM phenylmethylsulfonyl fluoride [PMSF], and 200 U/
ml RNase inhibitor) at 4˚C for 15 minutes with gentle rocking. Lysates were first centrifuged
at 2,000 × g for 5 minutes at 4˚C, and the supernatant was collected and further clarified by
centrifugation at 20,000 × g for 10 minutes at 4˚C. After clarification by centrifugation, 30 μl
of soluble extracts were retained as input, and the remaining soluble extract was incubated
with anti-GFP antibody (NeuroMab, Davis, California, USA) at 4˚C for 1.5 hours with gentle
rocking. Pre-equilibrated Protein G magnetic beads (New England BioLabs, Ipswich, Massa-
chusetts, USA) were added to the extracts and further incubated at 4˚C for 1.5 hours with gen-
tle rocking. The beads were washed 4 times with a wash buffer (20 mM HEPES-KOH pH 7.4,
350 mM KCl, 5 mM MgCl2, 1%(v/v) NP-40, 100 μg/ml cycloheximide, 1 mM DTT, 1 mM
PMSF, and 200 U/ml RNase inhibitor) prior to RNA extraction. Input and translating ribo-
some-associated RNAs were purified using an RNeasy Mini kit (QIAGEN, Hilden, Germany)
according to the manufacturer’s instructions.
Differential gene expression analysis by RNA sequencing
Ribosomal RNA was depleted from 50 ng of purified RNA samples using an rRNA depletion
kit (New England BioLabs). cDNA libraries for RNA sequencing were generated using a NEB-
Next Ultra Directional RNA Library Prep Kit for Illumina according to the manufacturer’s
instructions (New England BioLabs). The quality of sequencing libraries, defined by RNA
integrity number (RIN) values, was examined using a DNA1000 chip (Agilent, Santa Clara,
California, USA) and Agilent Technologies 2100 Bioanalyzer. After quantification by
qRT-PCR using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, California,
USA), an equimolar amount of index-tagged libraries was pooled into a single sample. Clusters
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were generated in the flow cell on the cBot automated cluster-generation system (Illumina,
San Diego, California, USA). RNA sequencing was performed on a NovaSeq 6000 system (Illu-
mina) with a 2× 100-bp read length (DNA Link, Seoul, Korea). Sequence reads were first
mapped to the reference genome (Human hg19) using Tophat (v2.0.13) [130,131], yielding 50
to 75 million mapped reads per sample. The aligned results were added to Cuffdiff (v2.2.0),
and differentially expressed genes (DEGs) were identified using the Cuffdiff output file, “gen-
e_exp.diff.”
Immunoprecipitation (IP)
SH-SY5Y cells on a 100-mm dish were collected and lysed in a lysis buffer (25 mM Tris-Cl pH
7.5, 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM DTT, 0.5%(v/v) NP-40, and 1 mM
PMSF) at 4˚C for 15 minutes with gentle rocking. After clarification by centrifugation, 30 μl of
soluble extracts were retained as input, and the remaining soluble extract was incubated with
2 μg of antibody or control IgG at 4˚C for 1.5 hours with gentle rocking. Pre-equilibrated Pro-
tein G magnetic beads (New England BioLabs) were added to the extracts and further incu-
bated at 4˚C for 1.5 hours with gentle rocking. The beads were then washed 5 times in the
same buffer. Input samples and immunoprecipitates were resolved by SDS-PAGE on 6.5% and
10% gels, and then proteins in each gel were transferred to Protran nitrocellulose membranes
(GE Healthcare, Chicago, Illinois, USA) and incubated with a specific set of primary antibod-
ies. The primary antibodies used in immunoblotting were mouse anti-RAN (1:1,000; Santa
Cruz Biotechnology), mouse anti-importin β1 (1:1,000; Santa Cruz Biotechnology), mouse
anti-RANGAP1 (1:1,000; Santa Cruz Biotechnology), mouse anti-RANBP2 (1:1,000; Santa
Cruz Biotechnology), mouse anti-EPAC1 (1:500; Santa Cruz Biotechnology), rabbit anti-
LSM12 (1:2,000), rabbit anti-p-EIF2α (1:2,000; Cell signaling), mouse anti-EIF2α (1:1,000;
Santa Cruz Biotechnology), mouse anti-tubulin (1:1,000; Developmental Studies Hybridoma
Bank), rabbit anti-ATXN2 (1:2,000; Proteintech), rabbit anti-ATXN2L (1:2,000; Medico,
Ansan, Korea), mouse anti-PABPC1 (1:1,000; Santa Cruz Biotechnology), and mouse anti-
FLAG (1:2,000; Sigma-Aldrich). Immunoreactive proteins were recognized by species-specific
horseradish peroxidase-conjugated secondary antibodies (Jackson Immuno Research Labora-
tories), with subsequent detection by Clarity Western ECL blotting substrate (Bio-Rad, Hercu-
les, California, USA) using ImageQuant LAS 4000 (GE Healthcare).
Quantification and statistical analysis
Quantification procedures for all experimental analyses are described in figure legends and
Materials and Methods above. Microsoft Excel and GraphPad Prism 8 software were used for
Student t test, 1-way analysis of variance (ANOVA), and 2-way ANOVA with post hoc tests.
The statistical details of experiments, including the number of experiments and samples ana-
lyzed, the statistical tests used, and P values, are described in the figure legends.
Supporting information
S1 Fig. LSM12 depletion impairs SG assembly under arsenite-induced oxidative stress. (A)
Puromycin treatment enhances arsenite-induced SG formation in controlshRNA cells, but not
in LSM12shRNA cells. ControlshRNA and LSM12shRNA cells were preincubated with puromycin
(5 μg/ml) or PBS (vehicle control) for 15 minutes before the induction of chronic oxidative
stress (50-μM NaAsO2, 2 hours). Cells were co-stained with anti-G3BP1 antibody (red), anti-
PABPC1 antibody (green), and Hoechst 33258 (blue) to visualize SGs and the nucleus, respec-
tively. The percentage of SG-positive cells, the number of SGs per cell, and the size of SGs were
quantified using ImageJ software and averaged (n = 10 confocal images obtained from 3
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independent experiments; n = 713–939 cells). Error bars indicate SEM. n.s., not significant;
�P< 0.05, ��P< 0.01, ���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc
test. (B) LSM12 depletion altered the kinetics of SG disassembly during the recovery from
acute oxidative stress. ControlshRNA and LSM12shRNA cells were incubated with 500-μM
NaAsO2 for 1 hour and then washed with fresh media. Cells were fixed at the indicated time
after the removal of NaAsO2 and co-stained with anti-G3BP1 antibody (red), anti-PABPC1
antibody (green), and Hoechst 33258 (blue). (C) The kinetics of SG disassembly were quanti-
fied similarly as above. Data represent means ± SEM (n = 8–10 confocal images obtained from
3 independent experiments; n = 388–740 cells). �P< 0.05, ��P< 0.01, ���P< 0.001, as deter-
mined by Student t test. All underlying numerical values are available in S1 Data. ANOVA,
analysis of variance; LSM12, like-Sm protein 12; SG, stress granule; SEM, standard error of the
mean.
(TIFF)
S2 Fig. Decreased phosphorylation of EIF2α underlies the impairment of arsenite-induced
SG formation in LSM12-depleted cells. (A) LSM12 depletion does not suppress the SG
assembly under sorbitol-induced osmotic stress. ControlshRNA and LSM12shRNA cells were
incubated with 0.4-M sorbitol for the indicated time before co-staining with anti-ATXN2 anti-
body (red), anti-G3BP1 antibody (green), and Hoechst 33258 (blue). (B, C) LSM12 depletion
decreases the arsenite-induced phosphorylation of EIF2α. ControlshRNA and LSM12shRNA cells
were incubated with 50-μM NaAsO2, 1-μM thapsigargin (Tg), or 0.4-M sorbitol for the indi-
cated time before harvest. Whole-cell lysates were immunoblotted with specific antibodies
(left). Relative levels of EIF2α phosphorylation were calculated by normalizing the ratio of
phospho-EIF2α to EIF2α protein levels per condition to that in control cells with no chemical
treatment. Data represent means ± SEM (n = 3). n.s., not significant; �P< 0.05, ��P< 0.01, as
determined by Student t test. All underlying numerical values are available in S1 Data.
ATXN2, ataxin-2; EIF2α, eukaryotic translation initiation factor 2 subunit α; LSM12, like-Sm
protein 12; SEM, standard error of the mean; SG, stress granule.
(TIFF)
S3 Fig. LSM12 depletion exacerbates the impairment of NCT caused by arsenite-induced
oxidative stress. (A) LSM12 depletion facilitates the nuclear mislocalization of S-GFP under
oxidative stress conditions. ControlshRNA and LSM12shRNA cells were transfected with an
S-GFP expression vector and then treated with 50-μM NaAsO2 for the indicated time before
co-staining with anti-G3BP1 antibody (red) and Hoechst 33258 (blue). NCT of S-GFP reporter
proteins was quantified as in Fig 2B. Data represent means ± SEM (n = 123–127 cells from 3
independent experiments). �P< 0.05, ��P< 0.01, ���P< 0.001 to controlshRNA cells at a given
time point, as determined by Student t test. (B) LSM12 depletion facilitates the cytoplasmic
mislocalization of S-tdT under oxidative stress conditions. Data represent means ± SEM
(n = 103–118 cells from 3 independent experiments). n.s., not significant; �P< 0.05,
��P< 0.01 to controlshRNA cells at a given time point, as determined by Student t test. All
underlying numerical values are available in S1 Data. GFP, green fluorescent protein; LSM12,
like-Sm protein 12; NCT, nucleocytoplasmic transport; S-tdT, S-tdTomato; SEM, standard
error of the mean.
(TIFF)
S4 Fig. LSM12 deletion increases the toxicity of C9ORF72-derived poly(GR) protein. (A)
LSM12 deletion exacerbates the poly(GR)-induced invaginations of the nuclear envelope. Con-
trol and LSM12KO cells were transfected with a GFP-GR100 expression vector and then co-
stained with anti-lamin B1 antibody (red) and Hoechst 33258 (blue) 48 hours after
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transfection. Yellow arrows indicate GFP-GR100–positive cells with severe nuclear lamina dis-
ruption. (B) The assembly of nuclear poly(GR) granules was quantified as in Fig 1. Data repre-
sent mean ± SEM (n = 15–17 confocal images obtained from 3 independent experiments;
n = 403–418 GFP-GR100–positive cells). ���P< 0.001, as determined by Student t test. (C) The
abnormal morphology of the nuclear lamina was quantified as in Fig 3E. Data represent
means ± SEM (n = 18–19 confocal images obtained from 3 independent experiments;
n = 366–413 GFP–or GFP-GR100–positive cells). n.s., not significant; ���P< 0.001, as deter-
mined by 2-way ANOVA with Tukey post hoc test. All underlying numerical values are avail-
able in S1 Data. ANOVA, analysis of variance; GFP, green fluorescent protein; LSM12, like-
Sm protein 12; SEM, standard error of the mean.
(TIFF)
S5 Fig. LSM12V135I overexpression does not alter the relative levels of endogenous LSM12
protein. (A) SH-SY5Y cells were transfected with an expression vector for FLAG, LSM12-
FLAG, or LSM12V135I-FLAG. Total cell extracts were prepared 48 hours after transfection and
immunoblotted with anti-FLAG, anti-LSM12, anti-ATXN2, anti-PABPC1, and anti-tubulin
(loading control) antibodies. Overexpression of wild-type LSM12, but not LSM12V135I,
increased the relative levels of endogenous ATXN2 protein, consistent with low levels of
endogenous ATXN2 protein in LSM12-depleted cells (Fig 1C). (B) The abundance of each
protein was quantified as in Fig 1C. Data represent means ± SEM (n = 4). n.s., not significant;
���P< 0.001, as determined by 1-way ANOVA with Dunnett post hoc test. All underlying
numerical values are available in S1 Data. ANOVA, analysis of variance; ATXN2, ataxin-2;
LSM12, like-Sm protein 12; SEM, standard error of the mean.
(TIFF)
S6 Fig. Quantitative analyses of total mRNAs (RNA-seq) and translating ribosome-associ-
ated mRNAs (TRAP-seq) are reproducible between 2 biological replicates of controlshRNA
and LSM12shRNA cells. The scatter plots of RNA-seq and TRAP-seq analyses were obtained
from 2 biological replicates of controlshRNA and LSM12shRNA cells. Pearson correlation and
P values are indicated in each plot. All underlying numerical values are available in S1 Data.
LSM12, like-Sm protein 12; RNA-seq, RNA sequencing; TRAP-seq, translating ribosome affin-
ity purification sequencing.
(TIFF)
S7 Fig. LSM12 deletion posttranscriptionally down-regulates EPAC1 expression. (A)
LSM12-deleted (LSM12KO) cells express low levels of EPAC1 protein. The abundance of each
protein was quantified as in Fig 1C. Data represent means ± SEM (n = 3). ��P< 0.01, as deter-
mined by Student t test. (B) A schematic representation of the EPAC1 locus and EPAC1
reporter constructs. Transcription of control and EPAC1 UTR reporters was driven by heterol-
ogous CMV promoter. A promoter region in the EPAC1 locus (from −1,805 to +71 in relative
to the transcription start site +1) was subcloned upstream of the NLUC-coding sequence to
measure the EPAC1 promoter activity by the NLUC activity. (C) LSM12 deletion posttran-
scriptionally decreases EPAC1 expression via the 50 UTR. Control and LSM12KO cells were co-
transfected with each EPAC1 reporter and a FLUC expression vector (normalizing control).
Luciferase reporter assays were performed as in Fig 5D. Data represent means ± SEM (n = 3).
n.s., not significant; �P< 0.05, ��P< 0.01 as determined by Student t test. All underlying
numerical values are available in S1 Data. CMV, cytomegalovirus; EPAC1, exchange protein
directly activated by cyclic AMP 1; FLUC, firefly luciferase; LSM12, like-Sm protein 12;
NLUC, Nano-luciferase; SEM, standard error of the mean; UTR, untranslated region.
(TIFF)
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S8 Fig. EPAC1 depletion is sufficient to phenocopy loss of LSM12 function in poly(GR)
toxicity. (A) SH-SY5Y cells were transfected with control or 2 independent EPAC1 siRNAs.
Total cell extracts were prepared 72 hours after transfection and immunoblotted with anti-
EPAC1 or anti-tubulin (loading control) antibodies. (B) LSM12 deletion and EPAC1 depletion
nonadditively disrupt the RAN gradient. Control and LSM12KO cells were transfected with
controlsiRNA or EPAC1siRNA. The nucleocytoplasmic RAN gradient was quantified as in Fig
2D. Data represent means ± SEM (n = 62–67 cells from 3 independent experiments). n.s., not
significant; ���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc test. (C, D)
EPAC1 depletion exacerbates the poly(GR)-induced disruption of NCT in an ISRIB-insensi-
tive manner. SH-SY5Y cells were co-transfected with siRNA and expression vectors for S-tdT
and GFP-GR100, as in Fig 6A. Where indicated, transfected cells were incubated with 2-μM
ISRIB or DMSO (vehicle control) for 5 hours before co-staining with anti-G3BP1 antibody
(magenta) and Hoechst 33258 (blue) at 48 hours after plasmid DNA transfection. NCT of S-
tdT reporter proteins was quantified as in Fig 2B. Two-way ANOVA detected significant inter-
action effects of GFP-GR100 and ISRIB treatment on NCT in control
siRNA cells (P = 0.0097),
but not in EPAC1siRNA cells (P = 0.5310 for EPAC1siRNA #1; P = 0.5218 for EPAC1siRNA #2);
significant interaction effects of GFP-GR100 and EPAC1 depletion on NCT regardless of ISRIB
treatment (P = 0.0194 for EPAC1siRNA #1 in DMSO; P = 0.0133 for EPAC1siRNA #2 in DMSO;
P< 0.0001 for both EPAC1siRNA in ISRIB). Data represent means ± SEM (n = 128–140 GFP–
or GFP-GR100–positive cells from 3 independent experiments).
�P< 0.05, ��P< 0.01,
���P< 0.001, as determined by Tukey post hoc test. (E) EPAC1 depletion increases the cell
population positive for poly(GR)-induced SGs but suppresses the maturation of poly(GR)-
induced SGs. SH-SY5Y cells were co-transfected with siRNA and a GFP-GR100 expression vec-
tor, as described in Fig 6C. The assembly of poly(GR)-induced SGs was quantified as in Fig 1.
Data represent means ± SEM (n = 10–12 confocal images obtained from 3 independent experi-
ments; n = 239–275 GFP-GR100–positive cells). n.s., not significant; �P< 0.05, ���P< 0.001, as
determined by Student t test. All underlying numerical values are available in S1 Data.
ANOVA, analysis of variance; EPAC1, exchange protein directly activated by cyclic AMP 1;
GFP, green fluorescent protein; ISRIB, integrated stress response inhibitor; LSM12, like-Sm
protein 12; NCT, nucleocytoplasmic transport; RAN, repeat-associated non-AUG; S-tdT, S-
tdTomato; SEM, standard error of the mean; siRNA, small interfering RNA.
(TIFF)
S9 Fig. Poly(GR)-induced neurodegeneration is exacerbated in Drosophila Epac mutants.
(A) Loss of Epac function exacerbates the neurodegenerative effects of C9ORF72-derived poly
(GR) proteins in a Drosophila eye model. Transgenic GR36 protein was overexpressed in pho-
toreceptor neurons (GMR>GR36) of wild-type (control), heterozygous Epac-deletion mutant
(EpacΔ), or EPAC-depleted flies (EpacRNAi #1, v50372; EpacRNAi #2, v110077). Representative
images of 1-week-old male flies per genotype are shown for ommatidial disorganization and
necrotic spots. GMR served as transgenic controls. (B) The eye phenotypes were scored in
individual transgenic flies (n = 123–170; weak, moderate, strong), and their relative distribu-
tion was calculated for each genotype. ���P< 0.001, as determined by chi-squared test. (C)
Two Epac RNAi transgenes (EpacRNAi #1, v50372; EpacRNAi #2, v110077) were individually
overexpressed in the Drosophila photoreceptor neurons by GMR-GAL4 driver. Total RNA
was prepared from fly heads. The abundance of Epac transcripts was quantified by real-time
RT-PCR and normalized to that of poly(A)-binding protein. Relative Epac mRNA levels were
then calculated by normalizing to those in GMR-GAL4/+ heterozygous controls. Data repre-
sent means ± SEM (n = 3). �P< 0.05, ���P< 0.001, as determined by 1-way ANOVA with
Dunnett post hoc test. All underlying numerical values are available in S1 Data. ANOVA,
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analysis of variance; EPAC, exchange protein directly activated by cyclic AMP 1; GMR, glass
multiple reporter; RT-PCR, reverse transcription PCR; SEM, standard error of the mean.
(TIFF)
S10 Fig. C9-ALS iPSCs and their isogenic control cells exhibit comparable efficiency of
motor neuron differentiation. (A) C9-ALS iPSNs (CS29) and isogenic control iPSNs
(CS29-ISO) were fixed 7 days (1-week-old) or 21 days (3-week-old) after neuronal differentia-
tion from their parental NPCs. Immunofluorescence assays were performed using anti-ChAT
antibody (red), anti-MAP2 antibody (green), anti-HB9 antibody (magenta), and Hoechst
33258 (blue). The percentages of MAP2-positive (a neuronal marker), ChAT-positive (cholin-
ergic neurons), and HB9-positive cells (motor neurons) were calculated and averaged (n = 7
confocal images from 3 independent experiments; n = 511–624 Hoechst–positive cells). Error
bars indicate SEM. n.s., not significant; as determined by 2-way ANOVA with Tukey post hoc
test. (B) poly(GR) aggregates are readily detectable in C9-ALS iPSNs, but not isogenic control
neurons. iPSNs were co-stained with anti-MAP2 antibody (green), anti-poly(GR) antibody
(red), and Hoechst 33258 (blue) similarly as above. All underlying numerical values are avail-
able in S1 Data. ANOVA, analysis of variance; C9-ALS, C9ORF72-associated amyotrophic lat-
eral sclerosis; NPC, neural progenitor cell; SEM, standard error of the mean.
(TIFF)
S11 Fig. Lentiviral overexpression of LSM12 or EPAC1 negligibly affects the efficiency of
neuronal differentiation from NPCs. (A) SH-SY5Y cells were infected with individual
recombinant lentiviruses that express the indicated FLAG-tagged proteins along with a GFP
reporter. Total cell extracts were prepared 48 hours after infection and immunoblotted with
anti-FLAG, anti-GFP, and anti-tubulin (loading control) antibodies. (B) NPCs from C9-ALS
iPSCs (CS29) and their isogenic control cells (CS29-ISO) were transduced with the indicated
recombinant lentiviruses. Three-week-old iPSNs were fixed and co-stained with anti-MAP2
antibody (magenta) and Hoechst 33258 (blue). (C) The percentages of MAP2–positive neu-
rons among GFP–positive cells were calculated and averaged (n = 8 confocal images obtained
from 4 independent experiments; n = 123–156 GFP–positive cells). Error bars indicate SEM.
n.s., not significant; as determined by 2-way ANOVA with Tukey post hoc test. All underlying
numerical values are available in S1 Data. ANOVA, analysis of variance; EPAC1, exchange
protein directly activated by cyclic AMP 1; GFP, green fluorescent protein; iPSC, induced plu-
ripotent stem cell; LSM12, like-Sm protein 12; NPC, neural progenitor cells; SEM, standard
error of the mean.
(TIFF)
S12 Fig. Lentiviral overexpression of LSM12 or EPAC1 suppresses caspase-3 activation in
C9-ALS iPSNs. Three-week-old C9-ALS iPSNs (CS28 and CS52) and control iPSNs (CS0 and
CS4) were fixed and co-stained with anti-cleaved caspase-3 antibody, anti-MAP2 antibody,
and Hoechst 33258. The relative percentages of iPSNs expressing cleaved caspase-3 were quan-
tified as in Fig 7H. Data represent means ± SEM (n = 828–1,122 GFP-positive cells from 3
independent differentiation experiments). n.s., not significant; �P< 0.05, ��P< 0.01,
���P< 0.001, as determined by 2-way ANOVA with Tukey post hoc test. All underlying
numerical values are available in S1 Data. ANOVA, analysis of variance; C9-ALS,
C9ORF72-associated amyotrophic lateral sclerosis; EPAC1, exchange protein directly activated
by cyclic AMP 1; GFP, green fluorescent protein; LSM12, like-Sm protein 12; SEM, standard
error of the mean.
(TIFF)
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S13 Fig. LSM12 and EPAC1 promote the association of RAN and Importin β1 with the
RANBP2-RANGAP1 complex. (A) LSM12 deletion dissociates RAN and importin β1 from
the RANBP2-RANGAP1 complex. Soluble extracts from control or LSM12KO cells were
immunoprecipitated with control IgG or anti-RANGAP1 antibody. IP complexes were ana-
lyzed as in Fig 8A. Asterisks indicate SUMOylated RANGAP1. Input, 4.5% of soluble extracts
used in each IP. (B) A selective activator of EPAC1 (8-pCPT-20-O-Me-cAMP-AM/007-AM)
does not rescue the association of RAN and importin β1 with the RANBP2-RANGAP1 com-
plex in LSM12-deleted cells. Where indicated, cells were preincubated with 1-μM 007-AM or
DMSO (vehicle control) at 37˚C for 1 hour before immunoprecipitating soluble cell extracts
with control IgG or anti-RANBP2 antibody. (C, D) EPAC1 depletion dissociates RAN and
importin β1 from the RANBP2-RANGAP1 complex. Soluble extracts from control or EPAC1
siRNA-transfected cells were immunoprecipitated with anti-RANBP2 (C) or anti-RANGAP1
antibodies (D). EPAC1, exchange protein directly activated by cyclic AMP 1; IP, immunopre-
cipitation; LSM12, like-Sm protein 12; RAN, repeat-associated non-AUG; RANBP2, Ran-
binding protein 2; RANGAP1, RAN GTPase-activating protein 1.
(TIFF)
S14 Fig. RAN overexpression suppresses the effects of EPAC1 depletion on the poly(GR)-
induced disruption of NCT. (A) SH-SY5Y cells were co-transfected with siRNA and expres-
sion vectors for S-tdT, GFP-GR100, and RAN-FLAG, as in Fig 6A. Transfected cells were co-
stained with anti-FLAG antibody (magenta) and Hoechst 33258 (blue) 48 hours after plasmid
DNA transfection. (B) NCT of S-tdT reporter proteins was quantified as in Fig 2A. Two-way
ANOVA detected significant interaction effects of GFP-GR100 and EPAC1 depletion on NCT
only in FLAG-expressing cells (P = 0.0005 for EPAC1siRNA #1; P = 0.0093 for EPAC1siRNA #2).
Data represent means ± SEM (n = 113–115 GFP–or GFP-GR100–positive cells from 3 indepen-
dent experiments). n.s., not significant; �P< 0.05, ��P< 0.01, ���P< 0.001, as determined by
Tukey post hoc test. All underlying numerical values are available in S1 Data. GFP, green fluo-
rescent protein; NCT, nucleocytoplasmic transport; RAN, repeat-associated non-AUG; S-tdT,
S-tdTomato; SEM, standard error of the mean; siRNA, small interfering RNA.
(TIFF)
S15 Fig. A model for the LSM12-EPAC1 pathway that establishes the nucleocytoplasmic
RAN gradient and suppresses the toxicity of C9ORF72-derived poly(GR) protein. The
LSM12-EPAC1 pathway contributes to the assembly of the RAN-associating protein complex
at the cytoplasmic side of the nuclear pore, thereby facilitating RAN-GTP recycling. The loss-
of-function of the LSM12-EPAC1 pathway dissociates RAN and importin β1 from the RANB-
P2-RANGAP1 complex and delays the nuclear entry of RAN for recycling. Disruption of the
RAN gradient impairs NCT, promotes the nuclear assembly of poly(GR) granules, and
increases poly(GR) toxicity (e.g., loss of nuclear laminar integrity and degeneration of Dro-
sophila photoreceptor neurons). Asterisks indicate stronger interaction between RANBP2 and
RANGAP1 caused by the loss of the LSM12-EPAC1 pathway. All underlying numerical values
are available in S1 Data. EPAC1, exchange protein directly activated by cyclic AMP 1; LSM12,
like-Sm protein 12; RAN, repeat-associated non-AUG; RANBP2, Ran-binding protein 2;
RANGAP1, RAN GTPase-activating protein 1.
(TIFF)
S1 Data. Numerical raw data in Figs 1–8 and S1–S12 and S14 Figs.
(XLSX)
S1 Raw Images. Original blot data in Figs 1, 5, 7 and 8 and S2, S5, S7, S8, S11 and S13 Figs.
(PDF)
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